蕭頌華醫生

蕭頌華醫生

心臟科專科醫生

香港大學內科學系榮譽臨床教授
香港大學內外全科醫學士
香港大學醫學博士
香港大學外科碩士
香港內科醫學院院士
香港醫學專科學院院士(內科)
英國倫敦皇家內科醫學院榮授院士

蕭頌華醫生現為心臟專科醫生和香港大學醫學院內科學系榮譽臨床教授。他於1997年在香港大學醫學院內外全科畢業(M.B.B.S.)並在瑪麗醫院接受心臟專科培訓。隨後蕭醫生在香港大學取得醫學博士學位(白文信金獎)和外科碩士學位。在2006-2007年,蕭醫生被授予著名的裘槎基金會研究生獎學金,在美國加州大學戴維斯分校接受研究生培訓。他於2008年加入香港大學擔任臨床助理教授展開了他教學及研究的學術生涯。彼於2013年晉陞為臨床副教授及2016年晉陞為臨床教授。2022年,蕭頌華醫生離開香港大學,開始私人執業。此外,蕭醫生亦為澳門大灣區心血管研究會及香港心血管疾病預防學會的聯合創始人及副主席。

學術文章

  1. Challenges in management of ST elevation myocardial infarction during COVID-19 pandemic. Tam CF, Siu CD, Tse HF. Cardiol Plus. 2021 Oct 1;6(4):218-230.
  2. A Risk Stratification Scheme for In-Hospital Cardiogenic Shock in Patients With Acute Myocardial Infarction. Yang JQ, Ran P, Li J, Zhong Q, Smith SC Jr, Wang Y, Fonarow GC, Qiu J, Morgan L, Wei XB, Chen XB, Huang JL, Hao YC, Zhou YL, Siu CW, Zhao D, Chen JY, Yu DQ. Front Cardiovasc Med. 2022 Mar 4;9:793497.
  3. Survivals of Angiography-Guided Percutaneous Coronary Intervention and Proportion of Intracoronary Imaging at Population Level: The Imaging Paradox. Ng AK, Ng PY, Ip A, Lam LT, Siu CW. Front Cardiovasc Med. 2022 Feb 24;9:792837.
  4. Risk of ischaemic and haemorrhagic stroke in Chinese undergoing percutaneous coronary intervention treated with potent P2Y12 inhibitor versus clopidogrel. Ng AK, Ng PY, Ip A, Lau KK, Siu CW. Stroke Vasc Neurol. 2022 Mar 9:svn-2021-001294.
  5. Opportunistic screening for asymptomatic left ventricular dysfunction in type 2 diabetes mellitus. Zhou M, Huang D, Cheng Y, Lau YM, Lai WH, Lau YM, Hai J, Lau CP, Chan EW, Yue WS, Zuo ML, Yin LX, Feng Y, Tan N, Chen J, Li XL, Tse HF, Lee CH, Chow WS, Siu CW, Wong CK. Postgrad Med J. 2022 Mar 8:postgradmedj-2022-141548.
  6. Impact of contrast-induced acute kidney injury on long-term major adverse cardiovascular events and kidney function after percutaneous coronary intervention: insights from a territory-wide cohort study in Hong Kong. Ng AK, Ng PY, Ip A, Lam LT, Ling IW, Wong AS, Yap DY, Siu CW. Clin Kidney J. 2021 Oct 22;15(2):338-346.
  7. Prognosis and treatment of atrial fibrillation in Asian cities: 1-year review of the Asia-Pacific Heart Rhythm Society Atrial Fibrillation Registry. Tse HF, Teo WS, Siu CW, Chao TF, Park HW, Shimizu W, Wong YK, Lip GYH. Europace. 2022 Jan 13:euab327.
  8. Trade-off of major bleeding versus myocardial infarction on mortality after percutaneous coronary intervention. Ng AK, Ng PY, Ip A, Lam LT, Siu CW. Open Heart. 2022 Jan;9(1):e001861.
  9. Carditis After COVID-19 Vaccination With a Messenger RNA Vaccine and an Inactivated Virus Vaccine : A Case-Control Study. Lai FTT, Li X, Peng K, Huang L, Ip P, Tong X, Chui CSL, Wan EYF, Wong CKH, Chan EWY, Siu DCW, Wong ICK. Ann Intern Med. 2022 Mar;175(3):362-370.
  10. Repurposing hyperpolarization-activated cyclic nucleotide-gated channels as a novel therapy for breast cancer. Mok KC, Tsoi H, Man EP, Leung MH, Chau KM, Wong LS, Chan WL, Chan SY, Luk MY, Chan JYW, Leung JKM, Chan YHY, Batalha S, Lau V, Siu DCW, Lee TKW, Gong C, Khoo US. Clin Transl Med. 2021 Nov;11(11):e578. doi: 10.1002/ctm2.578.
  11. Hospitalization and Mortality in Patients With Heart Failure Treated With Sacubitril/Valsartan vs. Enalapril: A Real-World, Population-Based Study. Pathadka S, Yan VKC, Li X, Tse G, Wan EYF, Lau H, Lau WCY, Siu DCW, Chan EW, Wong ICK. Front Cardiovasc Med. 2021 Jan 20;7:602363.
  12. Erratum: Drug Repurposing for the Treatment of COVID-19: A Knowledge Graph Approach. Yan VKC, Li X, Ye X, Ou M, Luo R, Zhang Q, Tang B, Cowling BJ, Hung I, Siu CW, Wong ICK, Cheng RCK, Chan EW. Adv Ther (Weinh). 2021 Oct;4(10):2100179.
  13. Determining propensity for sub-optimal low-density lipoprotein cholesterol response to statins and future risk of cardiovascular disease. Weng SF, Akyea RK, Man KK, Lau WCY, Iyen B, Blais JE, Chan EW, Siu CW, Qureshi N, Wong ICK, Kai J. PLoS One. 2021 Dec 2;16(12):e0260839.
  14. High-Intensity Statin vs. Low-Density Lipoprotein Cholesterol Target for Patients Undergoing Percutaneous Coronary Intervention: Insights From a Territory-Wide Cohort Study in Hong Kong. Ng AK, Ng PY, Ip A, Siu CW. Front Cardiovasc Med. 2021 Oct 28;8:760926.
  15. Importance of attributes and willingness to pay for oral anticoagulant therapy in patients with atrial fibrillation in China: A discrete choice experiment. Zhao J, Wang H, Li X, Hu Y, Yan VKC, Wong CKH, Guo Y, Cheung MKH, Lip GYH, Siu CW, Tse HF, Chan EW. PLoS Med. 2021 Aug 26;18(8):e1003730.
  16. Letter by Wong and Siu Regarding Article, “Microthrombi as a Major Cause of Cardiac Injury in COVID-19: A Pathologic Study”. Wong CK, Siu CW. Circulation. 2021 Aug 17;144(7):e156-e157.
  17. Association between proton pump inhibitors after percutaneous coronary intervention and risk of gastric cancer. Ng AK, Ng PY, Ip A, Cheung KS, Siu CW. BMJ Open Gastroenterol. 2021 Aug;8(1):e000719.
  18. Association Between Radial Versus Femoral Access for Percutaneous Coronary Intervention and Long-Term Mortality. Ng AK, Ng PY, Ip A, Jim MH, Siu CW. J Am Heart Assoc. 2021 Aug 3;10(15):e021256.
  19. Drug Repurposing for the Treatment of COVID-19: A Knowledge Graph Approach. Yan VKC, Li X, Ye X, Ou M, Luo R, Zhang Q, Tang B, Cowling BJ, Hung I, Siu CW, Wong ICK, Cheng RCK, Chan EW. Adv Ther (Weinh). 2021 May 20:2100055.
  20. Trends in lipid-modifying agent use in 83 countries. Blais JE, Wei Y, Yap KKW, Alwafi H, Ma TT, Brauer R, Lau WCY, Man KKC, Siu CW, Tan KCB, Wong ICK, Wei L, Chan EW. Atherosclerosis. 2021 Jul;328:44-51.
  21. Comparison Between Bare-Metal Stents, First-Generation Drug-Eluting Stents, and Bioresorbable Vascular Scaffolds. Ng AK, Ng PY, Siu CW, Jim MH. J Invasive Cardiol. 2021 Jun;33(6):E467-E473.
  22. Close Proximity of Leadless Pacemaker to Tricuspid Annulus Predicts Worse Tricuspid Regurgitation Following Septal Implantation. Hai JJ, Mao Y, Zhen Z, Fang J, Wong CK, Siu CW, Yiu KH, Lau CP, Tse HF. Circ Arrhythm Electrophysiol. 2021 May;14(5):e009530.
  23. Efficacy and Safety of Long-Term Evolocumab Use Among Asian Subjects - A Subgroup Analysis of the Further Cardiovascular Outcomes Research With PCSK9 Inhibition in Subjects With Elevated Risk (FOURIER) Trial. Keech AC, Oyama K, Sever PS, Tang M, Murphy SA, Hirayama A, Lu C, Tay L, Deedwania PC, Siu CW, Lira Pineda A, Choi D, Charng MJ, Amerena J, Wan Ahmad WA, Chopra VK, Pedersen TR, Giugliano RP, Sabatine MS; FOURIER Study Group. Circ J. 2021 Oct 25;85(11):2063-2070.
  24. Cardiac implantable electronic device surgery with interruption of warfarin forgoing post-operative bridging therapy in patients with moderate or high thromboembolic risks. Ng AK, Ng PY, Tam EW, Siu CW, Fan K. Thromb J. 2021 Apr 29;19(1):28.
  25. Cardiac magnetic resonance imaging-negative cardiac sarcoidosis. Yung SA, Ho JC, Yeung MCF, Chan C, Siu CW. Heart Rhythm Case Rep. 2021 Jan 1;7(3):139-143.
  26. Letter to the Editor on “Atrial fibrillation prevalence and risk profile from novel community-based screening in Thailand: A prospective multi-centre study”. Zuo ML, Wong CK, Yin L, Siu CW. Int J Cardiol Heart Vasc. 2021 Feb 22;33:100733.
  27. Editorial to “Improvement in quality of life and cardiac function after catheter ablation for asymptomatic persistent atrial fibrillation”. Lau CP, Lee KL, Siu CW, Tse HF. J Arrhythm. 2020 Dec 21;37(1):20-21.
  28. Observational study on wearable biosensors and machine learning-based remote monitoring of COVID-19 patients. Un KC, Wong CK, Lau YM, Lee JC, Tam FC, Lai WH, Lau YM, Chen H, Wibowo S, Zhang X, Yan M, Wu E, Chan SC, Lee SM, Chow A, Tong RC, Majmudar MD, Rajput KS, Hung IF, Siu CW. Sci Rep. 2021 Feb 23;11(1):4388.
  29. Trends in Cardiovascular Medicine Use in 65 Middle- and High-Income Countries. Yan VKC, Blais JE, Li X, Chui CSL, Wei L, Yan BP, Knapp MRJ, Siu CW, Wong ICK, Chan EW. J Am Coll Cardiol. 2021 Feb 23;77(7):1021-1023.
  30. A risk score to predict in-hospital mortality in patients with acute coronary syndrome at early medical contact: results from the Improving Care for Cardiovascular Disease in China-Acute Coronary Syndrome (CCC-ACS) Project. Ran P, Yang JQ, Li J, Li G, Wang Y, Qiu J, Zhong Q, Wang Y, Wei XB, Huang JL, Siu CW, Zhou YL, Zhao D, Yu DQ, Chen JY. Ann Transl Med. 2021 Jan;9(2):167.
  31. Body volume is the major determinant of worsening renal function in acutely decompensated heart failure with reduced left ventricular ejection fraction. Ho MH, Huang D, Ho CW, Zuo ML, Luo AG, Cheung E, Zhou M, Cheng Y, Liu M, Yiu KH, Lau CP, Yeung P, Yue WS, Yin LX, Tse HF, Jiang W, Lei Z, Li XL, Cowie M, Siu CW. Postgrad Med J. 2022 May;98(1159):333-340.
  32. Cardiovascular sequalae in uncomplicated COVID-19 survivors. Zhou M, Wong CK, Un KC, Lau YM, Lee JC, Tam FC, Lau YM, Lai WH, Tam AR, Lam YY, Pang P, Tong T, Tang M, Tse HF, Ho D, Ng MY, Chan EW, Wong ICK, Lau CP, Hung IF, Siu CW. PLoS One. 2021 Feb 11;16(2):e0246732.
  33. Factors associated with long-term major adverse cardiac events of coronary bioresorbable vascular scaffold. Ng AK, Ng PY, Siu CW, Jim MH. Cardiovasc Interv Ther. 2021 Oct;36(4):462-469.
  34. Different glycaemia-related risk factors for incident Alzheimer’s disease in men and women with type 2 diabetes-A sex-specific analysis of the Hong Kong diabetes database. Lee CH, Lui DTW, Cheung CYY, Woo YC, Fong CHY, Yuen MMA, Shea YF, Siu DCW, Chan KH, Chow WS, Lam KSL. Diabetes Metab Res Rev. 2021 Sep;37(6):e3401.
  35. Parkinson disease and leucine-rich repeat kinase 2 gene mutation: abridged secondary publication. Ho SL, Ho PWL, Siu DCW. Hong Kong Med J. 2020 Dec;26 Suppl 8(6):22-26.
  36. HbA1c variability, in addition to mean HbA1c, predicts incident hip fractures in Chinese people with type 2 diabetes. Lui DTW, Lee CH, Chan YH, Chow WS, Fong CHY, Siu DCW, Tse HF, Woo YC, Lam KSL. Osteoporos Int. 2020 Oct;31(10):1955-1964.
  37. Understanding the barriers to using oral anticoagulants among long-term aspirin users with atrial fibrillation – a qualitative study. Ng VWS, Siu CW, Chiu PKC, Kng CPL, Jamieson E, Wong ICK, Lam MPS. BMC Health Serv Res. 2020 Nov 25;20(1):1084.
  38. Antithrombotic therapy and the risk of new-onset dementia in elderly patients with atrial fibrillation. Wong CK, Huang D, Zhou M, Hai J, Yue WS, Li WH, Yin LX, Zuo ML, Feng YQ, Tan N, Chen JY, Kwan J, Siu CW. Postgrad Med J. 2022 Feb;98(1156):98-103.
  39. Patients Recovered From COVID-19 Show Ongoing Subclinical Myocarditis as Revealed by Cardiac Magnetic Resonance Imaging. Ng MY, Ferreira VM, Leung ST, Yin Lee JC, Ho-Tung Fong A, To Liu RW, Man Chan JW, Wu AKL, Lung KC, Crean AM, Fan-Ngai Hung I, Siu CW. JACC Cardiovasc Imaging. 2020 Nov;13(11):2476-2478.
  40. Point-of-care ultrasound augments physical examination learning by undergraduate medical students. Wong CK, Hai J, Chan KYE, Un KC, Zhou M, Huang D, Cheng YY, Li WH, Yin LX, Yue WS, Tse HF, Yeung P, Yip PS, Li VKS, Chan A, Cheung M, Cheung CW, Lau CP, Siu CW. Postgrad Med J. 2021 Jan;97(1143):10-15. doi: 10.1136/postgradmedj-2020-137773. Epub 2020 Oct 14.
  41. Human-Induced Pluripotent Stem Cell-Derived Cardiomyocytes Platform to Study SARS-CoV-2 Related Myocardial Injury. Wong CK, Luk HK, Lai WH, Lau YM, Zhang RR, Wong AC, Lo GC, Chan KH, Hung IF, Tse HF, Woo PC, Lau SK, Siu CW. Circ J. 2020 Oct 23;84(11):2027-2031.
  42. Protocol, rationale and design of DAbigatran for Stroke PreVention In Atrial Fibrillation in MoDerate or Severe Mitral Stenosis (DAVID-MS): a randomised, open-label study. Zhou M, Chan EW, Hai JJ, Wong CK, Lau YM, Huang D, Lam CC, Tam CCF, Wong YTA, Yung SYA, Chan KWK, Feng Y, Tan N, Chen JY, Yung CY, Lee KL, Choi CW, Lam H, Ng A, Fan K, Jim MH, Yiu KH, Yan BP, Siu CW. BMJ Open. 2020 Sep 25;10(9):e038194
  43. Short- and potential long-term adverse health outcomes of COVID-19: a rapid review. Leung TYM, Chan AYL, Chan EW, Chan VKY, Chui CSL, Cowling BJ, Gao L, Ge MQ, Hung IFN, Ip MSM, Ip P, Lau KK, Lau CS, Lau LKW, Leung WK, Li X, Luo H, Man KKC, Ng VWS, Siu CW, Wan EYF, Wing YK, Wong CSM, Wong KHT, Wong ICK. Emerg Microbes Infect. 2020 Dec;9(1):2190-2199.
  44. Artificial intelligence mobile health platform for early detection of COVID-19 in quarantine subjects using a wearable biosensor: protocol for a randomised controlled trial. Wong CK, Ho DTY, Tam AR, Zhou M, Lau YM, Tang MOY, Tong RCF, Rajput KS, Chen G, Chan SC, Siu CW, Hung IFN. BMJ Open. 2020 Jul 22;10(7):e038555.
  45. The impact of cigarette smoking in predicting stroke using CHADS2 and CHA2DS2-VASc schemas. Zuo ML, Li CM, Deng Y, Bhattacharyya S, Shuai P, Tse HF, Siu CW, Yin LX. Neurol Sci. 2021 Jan;42(1):159-166.
  46. Comparative Outcomes Between Direct Oral Anticoagulants, Warfarin, and Antiplatelet Monotherapy Among Chinese Patients with Atrial Fibrillation: A Population-Based Cohort Study. Li X, Pathadka S, Man KKC, Ng VWS, Siu CW, Wong ICK, Chan EW, Lau WCY. Drug Saf. 2020 Oct;43(10):1023-1033.
  47. Association Between Treatment With Apixaban, Dabigatran, Rivaroxaban, or Warfarin and Risk for Osteoporotic Fractures Among Patients With Atrial Fibrillation: A Population-Based Cohort Study. Lau WCY, Cheung CL, Man KKC, Chan EW, Sing CW, Lip GYH, Siu CW, Lam JKY, Lee ACH, Wong ICK. Ann Intern Med. 2020 Jul 7;173(1):1-9.
  48. Impact of coronavirus disease 2019 (COVID-19) outbreak on outcome of myocardial infarction in Hong Kong, China. Tam CF, Cheung KS, Lam S, Wong A, Yung A, Sze M, Fang J, Tse HF, Siu CW. Catheter Cardiovasc Interv. 2021 Feb 1;97(2):E194-E197.
  49. Impact of Coronavirus Disease 2019 (COVID-19) Outbreak on ST-Segment-Elevation Myocardial Infarction Care in Hong Kong, China. Tam CF, Cheung KS, Lam S, Wong A, Yung A, Sze M, Lam YM, Chan C, Tsang TC, Tsui M, Tse HF, Siu CW. Circ Cardiovasc Qual Outcomes. 2020 Apr;13(4):e006631.
  50. Risk of venous thromboembolism in Chinese pregnant women: Hong Kong venous thromboembolism study. Huang D, Wong E, Zuo ML, Chan PH, Yue WS, Hu HX, Chen L, Yin LX, Cui XW, Wu MX, Su X, Siu CW, Hai JJ. Blood Res. 2019 Sep;54(3):175-180.
  51. Guideline-Based Critical Care Pathway Improves Long-Term Clinical Outcomes in Patients with Acute Coronary Syndrome. Hai JJ, Wong CK, Un KC, Wong KL, Zhang ZY, Chan PH, Lam YM, Chan WS, Lam CC, Tam CC, Wong YT, Yung SY, Chan KW, Siu CW, Lau CP, Tse HF. Sci Rep. 2019 Nov 14;9(1):16814.
  52. Expression of Lmna-R225X nonsense mutation results in dilated cardiomyopathy and conduction disorders (DCM-CD) in mice: Impact of exercise training. Cai ZJ, Lee YK, Lau YM, Ho JC, Lai WH, Wong NL, Huang D, Hai JJ, Ng KM, Tse HF, Siu CW. Int J Cardiol. 2020 Jan 1;298:85-92.
  53. Thromboembolic, bleeding, and mortality risks among patients with nonvalvular atrial fibrillation treated with dual antiplatelet therapy versus oral anticoagulants: A population-based study. Lau WCY, Douglas IJ, Wong ICK, Smeeth L, Lip GYH, Leung WK, Siu CW, Cheung BMY, Mok MTC, Chan EW. Heart Rhythm. 2020 Jan;17(1):33-40.
  54. Screening Of Pulmonary Hypertension in Methamphetamine Abusers (SOPHMA): rationale and design of a multicentre, cross-sectional study. Cheng Y, Tung CK, Chung AKK, Liu WW, Huang D, Chan PH, Lam M, Chan WC, Siu CW, Hai JJ. BMJ Open. 2019 Aug 1;9(8):e027193.
  55. Incidence of dual antiplatelet therapy interruption within 1 year after primary percutaneous coronary intervention in patients with acute ST elevation myocardial infarction. Tam CC, Lee J, Chan KW, Lam CC, Wong YT, Chan E, Sze M, Lam YM, Chan C, Tse HF, Siu CW. Postgrad Med J. 2020 Jan;96(1131):9-13.
  56. Prognostic implications of statin intolerance in stable coronary artery disease patients with different levels of high-sensitive troponin. Hai JJ, Wong YK, Wong CK, Un KC, Chan PH, Siu CW, Yiu KH, Lau CP, Tse HF. BMC Cardiovasc Disord. 2019 Jul 15;19(1):168.
  57. TIMI risk score for secondary prevention of recurrent cardiovascular events in a real-world cohort of post-non-ST-elevation myocardial infarction patients. Huang D, Cheng YY, Wong YT, Yung SY, Chan KW, Lam CC, Hai J, Lau CP, Wong KL, Feng YQ, Tan N, Chen JY, Wu MX, Su X, Yan H, Song D, Tse HF, Chan PH, Siu CW, Tam CC. Postgrad Med J. 2019 Jul;95(1125):372-377.
  58. Thrombolysis in Myocardial Infarction Risk Score for Secondary Prevention of Recurrent Cardiovascular Events in a Real-World Cohort of Post-Acute Myocardial Infarction Patients. Huang D, Cheng YY, Wong YA, Yung SA, Tam CF, Chan KK, Lam CS, Yiu KH, Hai JJ, Lau CP, Chan EW, Chiang CE, Wong KL, Cheung T, Cheung BM, Feng YQ, Tan N, Chen JY, Yue WS, Hu HX, Chen L, Tse HF, Chan PH, Siu CW. Circ J. 2019 Mar 25;83(4):809-817.
  59. Genetic variations in familial hypercholesterolemia and cascade screening in East Asians. Chan ML, Cheung CL, Lee AC, Yeung CY, Siu CW, Leung JY, Pang HK, Tan KC. Mol Genet Genomic Med. 2019 Feb;7(2):e00520.
  60. Safety and feasibility of a midseptal implantation technique of a leadless pacemaker. Hai JJ, Fang J, Tam CC, Wong CK, Un KC, Siu CW, Lau CP, Tse HF. Heart Rhythm. 2019 Jun;16(6):896-902.
  61. Trends in statin prescription prevalence, initiation, and dosing: Hong Kong, 2004-2015. Blais JE, Chan EW, Law SWY, Mok MT, Huang D, Wong ICK, Siu CW. Atherosclerosis. 2019 Jan;280:174-182.
  62. Implantable cardioverter defibrillators in Asian population. Lau CP, Hai JJ, Siu CW. Pacing Clin Electrophysiol. 2018 Dec;41(12):1627-1629.
  63. Empagliflozin Ammeliorates High Glucose Induced-Cardiac Dysfuntion in Human iPSC-Derived Cardiomyocytes. Ng KM, Lau YM, Dhandhania V, Cai ZJ, Lee YK, Lai WH, Tse HF, Siu CW. Sci Rep. 2018 Oct 5;8(1):14872.
  64. Guidance on the management of familial hypercholesterolaemia in Hong Kong: an expert panel consensus viewpoint. Tomlinson B, Chan JC, Chan WB, Chen WW, Chow FC, Li SK, Kong AP, Ma RC, Siu DC, Tan KC, Wong LK, Yeung VT, But BW, Cheung PT, Fu CC, Tung JY, Wong WC, Yau HC. Hong Kong Med J. 2018 Aug;24(4):408-415.
  65. Strikingly Different Atheroprotective Effects of Apolipoprotein A-I in Early- Versus Late-Stage Atherosclerosis. Morton J, Bao S, Vanags LZ, Tsatralis T, Ridiandries A, Siu CW, Ng KM, Tan JTM, Celermajer DS, Ng MKC, Bursill CA. JACC Basic Transl Sci. 2018 May 30;3(2):187-199.
  66. Sex-Based Differences in Outcomes of Oral Anticoagulation in Patients With Atrial Fibrillation. Law SWY, Lau WCY, Wong ICK, Lip GYH, Mok MT, Siu CW, Chan EW. J Am Coll Cardiol. 2018 Jul 17;72(3):271-282.
  67. Effectiveness of a nongovernmental organization-led large-scale community atrial fibrillation screening program using the smartphone electrocardiogram: An observational cohort study. Chan NY, Choy CC, Chan CK, Siu CW. Heart Rhythm. 2018 Sep;15(9):1306-1311.
  68. Diagnostic assessment of a deep learning system for detecting atrial fibrillation in pulse waveforms. Poh MZ, Poh YC, Chan PH, Wong CK, Pun L, Leung WW, Wong YF, Wong MM, Chu DW, Siu CW. Heart. 2018 Dec;104(23):1921-1928.
  69. Secular trends and etiologies of venous thromboembolism in Chinese from 2004 to 2016. Huang D, Chan PH, She HL, Wong CK, Ho CW, Cheng YY, Chan EW, Chiang CE, Siu CW. Thromb Res. 2018 Jun;166:80-85.
  70. PostOperative ST-segment elevation: not a blocked coronary artery, then what? Sin WC, Kwong JM, Wong TC, Kwong C, Chan C, Siu CW. Clin Case Rep. 2018 Feb 16;6(4):631-633.
  71. Rationale and design of the screening of pulmonary hypertension in systemic lupus erythematosus (SOPHIE) study. Huang D, Cheng YY, Chan PH, Hai J, Yiu KH, Tse HF, Wong KL, Fan K, Li YW, Ng WL, Yim CW, Wong CJ, Tam LS, Wong PCH, Wong CY, Ho CH, Leung AMH, Mok CC, Lam H, Lau CS, Cheung T, Ho C, Law SWY, Chan EW, Yin LX, Yue WS, Mok TM, Evora MA, Siu CW. ERJ Open Res. 2018 Mar 6;4(1):00135-2017.
  72. Impact of provision of time in therapeutic range value on anticoagulation management in atrial fibrillation patients on warfarin. Huang D, Wong CL, Cheng KW, Chan PH, Yue WS, Wong CK, Ho CW, Wong ICK, Chan EW, Siu CW. Postgrad Med J. 2018 Apr;94(1110):207-211.
  73. Prognostic implications of early monomorphic and non-monomorphic tachyarrhythmias in patients discharged with acute coronary syndrome. Hai JJ, Un KC, Wong CK, Wong KL, Zhang ZY, Chan PH, Lau CP, Siu CW, Tse HF. Heart Rhythm. 2018 Jun;15(6):822-829.
  74. Guidance on the management of familial hypercholesterolaemia in Hong Kong: an expert panel consensus viewpoint. Tomlinson B, Chan JC, Chan WB, Chen WW, Chow FC, Li SK, Kong AP, Ma RC, Siu DC, Tan KC, Wong LK, Yeung VT, But BW, Cheung PT, Fu CC, Tung JY, Wong WC, Yau HC. Hong Kong Med J. 2018 Aug;24(4):408-415.
  75. Antiplatelet Resumption after Antiplatelet-Related Intracerebral Hemorrhage: A Retrospective Hospital-Based Study. Teo KC, Lau GKK, Mak RHY, Leung HY, Chang RSK, Tse MY, Lee R, Leung GKK, Ho SL, Cheung RTF, Siu DCW, Chan KH. World Neurosurg. 2017 Oct;106:85-91.
  76. WATCHMAN device-related thrombus successfully treated with apixaban: A case report. Wong CK, Chan PH, Lam CC, Kwok OH, Lam YY, Siu CW. Medicine (Baltimore). 2017 Nov;96(47):e8693.
  77. The diagnosis and treatment of venous thromboembolism in Asian patients. Wang KL, Yap ES, Goto S, Zhang S, Siu CW, Chiang CE. Thromb J. 2018 Jan 18;16:4.
  78. Genetically deprived vitamin D exposure predisposes to atrial fibrillation. Chan YH, Yiu KH, Hai JJ, Chan PH, Lam TH, Cowling BJ, Sham PC, Lau CP, Lam KS, Siu CW, Tse HF. Europace. 2017 Dec 1;19(suppl_4):iv25-iv31.
  79. Extrinsic pulmonary artery compression mimicking acute pulmonary embolism. Fang JX, Fang BX, Lam CS, Chan PH, Tam FC, Siu CW. Clin Case Rep. 2017 Aug 17;5(10):1591-1593.
  80. PR interval prolongation in coronary patients or risk equivalent: excess risk of ischemic stroke and vascular pathophysiological insights. Chan YH, Hai JJ, Lau KK, Li SW, Lau CP, Siu CW, Yiu KH, Tse HF. BMC Cardiovasc Disord. 2017 Aug 24;17(1):233.
  81. 2017 consensus of the Asia Pacific Heart Rhythm Society on stroke prevention in atrial fibrillation. Chiang CE, Okumura K, Zhang S, Chao TF, Siu CW, Wei Lim T, Saxena A, Takahashi Y, Siong Teo W. J Arrhythm. 2017 Aug;33(4):345-367.
  82. Modeling Treatment Response for Lamin A/C Related Dilated Cardiomyopathy in Human Induced Pluripotent Stem Cells. Lee YK, Lau YM, Cai ZJ, Lai WH, Wong LY, Tse HF, Ng KM, Siu CW. J Am Heart Assoc. 2017 Jul 28;6(8):e005677.
  83. Bleeding-related hospital admissions and 30-day readmissions in patients with non-valvular atrial fibrillation treated with dabigatran versus warfarin. Lau WCY, Li X, Wong ICK, Man KKC, Lip GYH, Leung WK, Siu CW, Chan EW.
  84. J Thromb Haemost. 2017 Oct;15(10):1923-1933.
  85. Diagnostic performance of an automatic blood pressure measurement device, Microlife WatchBP Home A, for atrial fibrillation screening in a real-world primary care setting. Chan PH, Wong CK, Pun L, Wong YF, Wong MM, Chu DW, Siu CW. BMJ Open. 2017 Jun 15;7(6):e013685.
  86. Quinidine for Brugada syndrome: Panacea or poison? Hai JJ, Wong CK, Chan PH, Tse HF, Yung TC, Siu CW. Heart Rhythm Case Rep. 2016 Aug 16;2(6):486-490.
  87. Screening for Atrial Fibrillation: A Report of the AF-SCREEN International Collaboration. Freedman B, Camm J, Calkins H, Healey JS, Rosenqvist M, Wang J, Albert CM, Anderson CS, Antoniou S, Benjamin EJ, Boriani G, Brachmann J, Brandes A, Chao TF, Conen D, Engdahl J, Fauchier L, Fitzmaurice DA, Friberg L, Gersh BJ, Gladstone DJ, Glotzer TV, Gwynne K, Hankey GJ, Harbison J, Hillis GS, Hills MT, Kamel H, Kirchhof P, Kowey PR, Krieger D, Lee VWY, Levin LÅ, Lip GYH, Lobban T, Lowres N, Mairesse GH, Martinez C, Neubeck L, Orchard J, Piccini JP, Poppe K, Potpara TS, Puererfellner H, Rienstra M, Sandhu RK, Schnabel RB, Siu CW, Steinhubl S, Svendsen JH, Svennberg E, Themistoclakis S, Tieleman RG, Turakhia MP, Tveit A, Uittenbogaart SB, Van Gelder IC, Verma A, Wachter R, Yan BP; AF-Screen Collaborators. Circulation. 2017 May 9;135(19):1851-1867.
  88. Association Between Dabigatran vs Warfarin and Risk of Osteoporotic Fractures Among Patients With Nonvalvular Atrial Fibrillation. Lau WC, Chan EW, Cheung CL, Sing CW, Man KK, Lip GY, Siu CW, Lam JK, Lee AC, Wong IC. JAMA. 2017 Mar 21;317(11):1151-1158.
  89. Letter by Wong et al Regarding Article, “Pregnancy and the Risk of Aortic Dissection or Rupture: A Cohort-Crossover Analysis”. Wong CK, Chan PH, Siu CW. Circulation. 2017 Mar 21;135(12):e780-e781.
  90. Generation of Human Liver Chimeric Mice with Hepatocytes from Familial Hypercholesterolemia Induced Pluripotent Stem Cells. Yang J, Wang Y, Zhou T, Wong LY, Tian XY, Hong X, Lai WH, Au KW, Wei R, Liu Y, Cheng LH, Liang G, Huang Z, Fan W, Zhao P, Wang X, Ibañez DP, Luo Z, Li Y, Zhong X, Chen S, Wang D, Li L, Lai L, Qin B, Bao X, Hutchins AP, Siu CW, Huang Y, Esteban MA, Tse HF. Stem Cell Reports. 2017 Mar 14;8(3):605-618.
  91. Androgen deprivation therapy and fracture risk in Chinese patients with prostate carcinoma. Lee CH, Huang G, Chan PH, Hai J, Yeung CY, Fong CH, Woo YC, Ho KL, Yiu MK, Leung F, Lau TW, Tse HF, Lam KS, Siu CW. PLoS One. 2017 Feb 3;12(2):e0171495.
  92. Prediction of Thromboembolic Events in Heart Failure Patients in Sinus Rhythm: The Hong Kong Heart Failure Registry. Hai JJ, Chan PH, Chan YH, Fong CH, Huang D, Li WH, Yin LX, Lau CP, Tse HF, Siu CW. PLoS One. 2016 Dec 30;11(12):e0169095.
  93. Head-to-Head Comparison of the AliveCor Heart Monitor and Microlife WatchBP Office AFIB for Atrial Fibrillation Screening in a Primary Care Setting. Chan PH, Wong CK, Pun L, Wong YF, Wong MM, Chu DW, Siu CW. Circulation. 2017 Jan 3;135(1):110-112.
  94. Efficacy and safety of dabigatran, rivaroxaban, and warfarin for stroke prevention in Chinese patients with atrial fibrillation: the Hong Kong Atrial Fibrillation Project. Li WH, Huang D, Chiang CE, Lau CP, Tse HF, Chan EW, Wong ICK, Lip GYH, Chan PH, Siu CW. Clin Cardiol. 2017 Apr;40(4):222-229.
  95. Amelioration of X-Linked Related Autophagy Failure in Danon Disease With DNA Methylation Inhibitor. Ng KM, Mok PY, Butler AW, Ho JC, Choi SW, Lee YK, Lai WH, Au KW, Lau YM, Wong LY, Esteban MA, Siu CW, Sham PC, Colman A, Tse HF. Circulation. 2016 Nov 1;134(18):1373-1389.
  96. Recent advances in animal and human pluripotent stem cell modeling of cardiac laminopathy. Lee YK, Jiang Y, Ran XR, Lau YM, Ng KM, Lai WH, Siu CW, Tse HF. Stem Cell Res Ther. 2016 Sep 20;7(1):139.
  97. Incidence and predictors of sudden arrhythmic death or ventricular tachyarrhythmias after acute coronary syndrome: An Asian perspective. Hai JJ, Tam E, Chan PH, Lau CP, Siu CW, Tse HF. Heart Rhythm. 2017 Jan;14(1):81-87.
  98. Letter by Chan and Siu Regarding Article, “Use of Oral Anticoagulants for Stroke Prevention in Patients With Atrial Fibrillation Who Have a History of Intracranial Hemorrhage”. Chan PH, Siu CW. Circulation. 2016 Sep 13;134(11):e226-7.
  99. Burden of upper gastrointestinal symptoms in patients prescribed dabigatran for stroke prevention. Chan PH, Hai JJ, Huang D, Ho MH, Chan EW, Cheung BM, Chan AO, Wong IC, Tse HF, Hung IF, Siu CW. SAGE Open Med. 2016 Aug 4;4:2050312116662414.
  100. Heart failure across Asia: Same healthcare burden but differences in organization of care. Reyes EB, Ha JW, Firdaus I, Ghazi AM, Phrommintikul A, Sim D, Vu QN, Siu CW, Yin WH, Cowie MR. Int J Cardiol. 2016 Nov 15;223:163-167.
  101. Gastrointestinal haemorrhage in atrial fibrillation patients: impact of quality of anticoagulation control. Chan PH, Li WH, Hai JJ, Chan KH, Tse HF, Cheung BM, Chan EW, Wong IC, Leung WK, Hung IF, Lip GY, Siu CW. Eur Heart J Cardiovasc Pharmacother. 2015 Oct;1(4):265-72.
  102. CHA2DS2-VASc Recalibration With an Additional Age Category (50-64 Years) Enhances Stroke Risk Stratification in Chinese Patients With Atrial Fibrillation. Chan PH, Lau CP, Tse HF, Chiang CE, Siu CW. Can J Cardiol. 2016 Dec;32(12):1381-1387.
  103. Diagnostic Performance of a Smartphone-Based Photoplethysmographic Application for Atrial Fibrillation Screening in a Primary Care Setting.
  104. Chan PH, Wong CK, Poh YC, Pun L, Leung WW, Wong YF, Wong MM, Poh MZ, Chu DW, Siu CW. J Am Heart Assoc. 2016 Jul 21;5(7):e003428.
  105. Improvement of surface ECG recording in adult zebrafish reveals that the value of this model exceeds our expectation. Liu CC, Li L, Lam YW, Siu CW, Cheng SH. Sci Rep. 2016 Apr 29;6:25073.
  106. Net Clinical Benefit of Dabigatran Over Warfarin in Patients With Atrial Fibrillation Stratified by CHA2DS2-VASc and Time in Therapeutic Range. Chan PH, Huang D, Lau CP, Chan EW, Wong IC, Lip GY, Tse HF, Siu CW. Can J Cardiol. 2016 Oct;32(10):1247.e15-1247.e21.
  107. Effect of suboptimal anticoagulation treatment with antiplatelet therapy and warfarin on clinical outcomes in patients with nonvalvular atrial fibrillation: A population-wide cohort study. Chan EW, Lau WC, Siu CW, Lip GY, Leung WK, Anand S, Man KK, Wong IC. Heart Rhythm. 2016 Aug;13(8):1581-8.
  108. Use of the SAMe-TT2R2 Score to Predict Good Anticoagulation Control with Warfarin in Chinese Patients with Atrial Fibrillation: Relationship to Ischemic Stroke Incidence. Chan PH, Hai JJ, Chan EW, Li WH, Tse HF, Wong IC, Lip GY, Siu CW. PLoS One. 2016 Mar 24;11(3):e0150674.
  109. Clinical Characteristics, Management, and Outcomes of Hospitalized Heart Failure in a Chinese Population-The Hong Kong Heart Failure Registry. Hai JJ, Chan PH, Huang D, Ho MH, Ho CW, Cheung E, Lau CP, Tse HF, Siu CW. J Card Fail. 2016 Aug;22(8):600-8.
  110. Time in Therapeutic Range and Percentage of International Normalized Ratio in the Therapeutic Range as a Measure of Quality of Anticoagulation Control in Patients With Atrial Fibrillation. Chan PH, Li WH, Hai JJ, Chan EW, Wong IC, Tse HF, Lip GY, Siu CW. Can J Cardiol. 2016 Oct;32(10):1247.e23-1247.e28.
  111. Ivabradine in Severe Aortic Stenosis with Poor Left Ventricular Ejection Fraction. Huang D, Chan PH, Lam CC, Shea PC, Yiu KH, Tse HF, Siu CW. J Heart Valve Dis. 2015 Jul;24(4):433-5.
  112. The association between non-vitamin K antagonist oral anticoagulants and gastrointestinal bleeding: a meta-analysis of observational studies. He Y, Wong IC, Li X, Anand S, Leung WK, Siu CW, Chan EW. Br J Clin Pharmacol. 2016 Jul;82(1):285-300.
  113. Subclinical atrial fibrillation and stroke: insights from continuous monitoring by implanted cardiac electronic devices. Lau CP, Siu CW, Yiu KH, Lee KL, Chan YH, Tse HF. Europace. 2015 Oct;17 Suppl 2:ii40-6.
  114. Cardiovascular outcomes associated with use of clarithromycin: population based study. Wong AY, Root A, Douglas IJ, Chui CS, Chan EW, Ghebremichael-Weldeselassie Y, Siu CW, Smeeth L, Wong IC. BMJ. 2016 Jan 14;352:h6926.
  115. Lysosomal membrane permeabilization is involved in oxidative stress-induced apoptotic cell death in LAMP2-deficient iPSCs-derived cerebral cortical neurons. Law CY, Siu CW, Fan K, Lai WH, Au KW, Lau YM, Wong LY, Ho JCY, Lee YK, Tse HF, Ng KM. Biochem Biophys Rep. 2016 Jan 14;5:335-345.
  116. Non-vitamin K Oral Anticoagulants Versus Warfarin for Patients with Atrial Fibrillation: Absolute Benefit and Harm Assessments Yield Novel Insights. Kumana CR, Cheung BM, Siu DC, Tse HF, Lauder IJ. Cardiovasc Ther. 2016 Apr;34(2):100-6.
  117. Generation and Characterization of Patient-Specific iPSC Model for Cardiovascular Disease. Lee YK, Ran X, Lai KW, Lau VY, Siu DC, Tse HF. Methods Mol Biol. 2016;1353:191-213.
  118. Exome-wide association analysis reveals novel coding sequence variants associated with lipid traits in Chinese. Tang CS, Zhang H, Cheung CY, Xu M, Ho JC, Zhou W, Cherny SS, Zhang Y, Holmen O, Au KW, Yu H, Xu L, Jia J, Porsch RM, Sun L, Xu W, Zheng H, Wong LY, Mu Y, Dou J, Fong CH, Wang S, Hong X, Dong L, Liao Y, Wang J, Lam LS, Su X, Yan H, Yang ML, Chen J, Siu CW, Xie G, Woo YC, Wu Y, Tan KC, Hveem K, Cheung BM, Zöllner S, Xu A, Eugene Chen Y, Jiang CQ, Zhang Y, Lam TH, Ganesh SK, Huo Y, Sham PC, Lam KS, Willer CJ, Tse HF, Gao W. Nat Commun. 2015 Dec 22;6:10206.
  119. Efficient attenuation of Friedreich’s ataxia (FRDA) cardiomyopathy by modulation of iron homeostasis-human induced pluripotent stem cell (hiPSC) as a drug screening platform for FRDA. Lee YK, Lau YM, Ng KM, Lai WH, Ho SL, Tse HF, Siu CW, Ho PW. Int J Cardiol. 2016 Jan 15;203:964-71.
  120. Ischaemic stroke in patients with atrial fibrillation with chronic kidney disease undergoing peritoneal dialysis. Chan PH, Huang D, Yip PS, Hai J, Tse HF, Chan TM, Lip GY, Lo WK, Siu CW. Europace. 2016 May;18(5):665-71.
  121. Stroke prevention using dabigatran in elderly Chinese patients with atrial fibrillation. Chan PH, Huang D, Hai JJ, Li WH, Yin LX, Chan EW, Wong IC, Lau CP, Chiang CE, Zhu J, Tse HF, Siu CW. Heart Rhythm. 2016 Feb;13(2):366-73.
  122. Clinical Benefit of Warfarin in Dialysis Patients With Atrial Fibrillation. Chan PH, Siu CW. J Am Coll Cardiol. 2015 Sep 15;66(11):1310-1311.
  123. Benefit of Anticoagulation Therapy in Hyperthyroidism-Related Atrial Fibrillation. Chan PH, Hai J, Yeung CY, Lip GY, Lam KS, Tse HF, Siu CW. Clin Cardiol. 2015 Aug;38(8):476-82.
  124. MRI of the cervical spine with 3D gradient echo sequence at 3 T: initial experience. Xiao L, Siu CW, Yeung K, Leung A, Yuen MK, Wong YC. Clin Radiol. 2015 Sep;70(9):926-31.
  125. Slow Heart Rate Predicts New Occurrence of Atrial Fibrillation. Hai J, Chan PH, Tse HF, Siu CW. Heart Lung Circ. 2015 Nov;24(11):1087-93.
  126. Impact of Antithrombotic Therapy in Atrial Fibrillation on the Presentation of Coronary Artery Disease. Chan PH, Li WH, Hai JJ, Tse HF, Siu CW. PLoS One. 2015 Jun 22;10(6):e0131479.
  127. One more “C” for CHA2DS2-VASc score? Siu CW. J Am Coll Cardiol. 2015 Apr 21;65(15):1602-3.
  128. Remodelling of cardiac sympathetic re-innervation with thoracic spinal cord stimulation improves left ventricular function in a porcine model of heart failure. Liao SY, Liu Y, Zuo M, Zhang Y, Yue W, Au KW, Lai WH, Wu Y, Shuto C, Chen P, Siu CW, Schwartz PJ, Tse HF. Europace. 2015 Dec;17(12):1875-83.
  129. Response to letter regarding article, “Ischemic stroke and intracranial hemorrhage with aspirin, dabigatran, and warfarin: impact of quality of anticoagulation control”. Chan PH, Hai JJ, Siu CW. Stroke. 2015 Mar;46(3):e72.
  130. Thoracic Spinal Cord Stimulation for Heart Failure as a Restorative Treatment (SCS HEART study): first-in-man experience. Tse HF, Turner S, Sanders P, Okuyama Y, Fujiu K, Cheung CW, Russo M, Green MDS, Yiu KH, Chen P, Shuto C, Lau EOY, Siu CW. Heart Rhythm. 2015 Mar;12(3):588-595.
  131. The CHADS2 and CHA2DS2-VASc scores predict adverse vascular function, ischemic stroke and cardiovascular death in high-risk patients without atrial fibrillation: role of incorporating PR prolongation. Chan YH, Yiu KH, Lau KK, Yiu YF, Li SW, Lam TH, Lau CP, Siu CW, Tse HF. Atherosclerosis. 2014 Dec;237(2):504-13.
  132. Vascular protective effects of statin-related increase in serum 25-hydroxyvitamin D among high-risk cardiac patients. Chan YH, Lau KK, Yiu KH, Li SW, Tam S, Lam TH, Lau CP, Siu CW, Cheung BM, Tse HF.
  133. J Cardiovasc Med (Hagerstown). 2015 Jan;16(1):51-8.
  134. Ischemic stroke and intracranial hemorrhage with aspirin, dabigatran, and warfarin: impact of quality of anticoagulation control. Ho CW, Ho MH, Chan PH, Hai JJ, Cheung E, Yeung CY, Lau KK, Chan KH, Lau CP, Lip GY, Leung GK, Tse HF, Siu CW. Stroke. 2015 Jan;46(1):23-30.
  135. Mediterranean-style diet is associated with reduced blood pressure variability and subsequent stroke risk in patients with coronary artery disease.Lau KK, Wong YK, Chan YH, Li OY, Lee PY, Yuen GG, Wong YK, Tong S, Wong D, Chan KH, Cheung RT, Siu CW, Ho SL, Tse HF. Am J Hypertens. 2015 Apr;28(4):501-7.
  136. Endothelin-1 overexpression exacerbate experimental allergic encephalomyelitis. Guo Y, Chung SK, Siu CW, Kwan SC, Ho PW, Yeung PK, Chan KH. J Neuroimmunol. 2014 Nov 15;276(1-2):64-70.
  137. Pseudo-pre-excitation unraveled down to its core. Ng AK, Ng KM, Tse HF, Lai WH, Chan WS, Siu CW, Fan K. Circulation. 2014 Aug 12;130(7):e56-8.
  138. Continuation of dabigatran therapy in “real-world” practice in Hong Kong. Ho MH, Ho CW, Cheung E, Chan PH, Hai JJ, Chan KH, Chan EW, Leung GK, Tse HF, Siu CW. PLoS One. 2014 Aug 1;9(8):e101245.
  139. Endomyocardial implantation of autologous bone marrow mononuclear cells in advanced ischemic heart failure: a randomized placebo-controlled trial (END-HF). Santoso T, Siu CW, Irawan C, Chan WS, Alwi I, Yiu KH, Aziz A, Kwong YL, Tse HF. J Cardiovasc Transl Res. 2014 Aug;7(6):545-52.
  140. Torsade de Pointes during oral arsenic trioxide therapy for acute promyelocytic leukemia in a patient with heart failure. Hai JJ, Gill H, Tse HF, Kumana CR, Kwong YL, Siu CW. Ann Hematol. 2015 Mar;94(3):501-3.
  141. Refinement of ischemic stroke risk in patients with atrial fibrillation and CHA2 DS2 -VASc score of 1. Huang D, Anguo L, Yue WS, Yin L, Tse HF, Siu CW. Pacing Clin Electrophysiol. 2014 Nov;37(11):1442-7.
  142. Visit-to-visit blood pressure variability as a prognostic marker in patients with cardiovascular and cerebrovascular diseases–relationships and comparisons with vascular markers of atherosclerosis. Lau KK, Wong YK, Chan YH, Teo KC, Chan KH, Wai Li LS, Cheung RT, Siu CW, Ho SL, Tse HF. Atherosclerosis. 2014 Jul;235(1):230-5.
  143. Roles of the CHADS2 and CHA2DS2-VASc scores in post-myocardial infarction patients: Risk of new occurrence of atrial fibrillation and ischemic stroke. Lau KK, Chan PH, Yiu KH, Chan YH, Liu S, Chan KH, Yeung CY, Li SW, Tse HF, Siu CW. Cardiol J. 2014;21(5):474-83.
  144. Long-term prognostic implications of visit-to-visit blood pressure variability in patients with ischemic stroke. Lau KK, Wong YK, Teo KC, Chang RS, Chan KH, Hon SF, Wat KL, Cheung RT, Li LS, Siu CW, Tse HF. Am J Hypertens. 2014 Dec;27(12):1486-94.
  145. Androgen deprivation therapy and cardiovascular risk in chinese patients with nonmetastatic carcinoma of prostate. Huang G, Yeung CY, Lee KK, Liu J, Ho KL, Yiu MK, Lam KS, Tse HF, Yau T, Siu CW. J Oncol. 2014;2014:529468.
  146. Risk of stroke and intracranial hemorrhage in 9727 Chinese with atrial fibrillation in Hong Kong. Siu CW, Lip GY, Lam KF, Tse HF. Heart Rhythm. 2014 Aug;11(8):1401-8.
  147. Overexpression of myocardin induces partial transdifferentiation of human-induced pluripotent stem cell-derived mesenchymal stem cells into cardiomyocytes. Zhang J, Ho JC, Chan YC, Lian Q, Siu CW, Tse HF. Physiol Rep. 2014 Feb 25;2(2):e00237.
  148. The effects of hyperuricaemia on flow-mediated and nitroglycerin-mediated dilatation in high-risk patients. Wong CK, Chen Y, Ho LM, Zhen Z, Siu CW, Tse HF, Yiu KH. Nutr Metab Cardiovasc Dis. 2014 Sep;24(9):1012-9.
  149. Angiographic result of T-stenting with small protrusion using drug-eluting stents in the management of ischemic side branch: the ARTEMIS study. Jim MH, Wu EB, Fung RC, Ng AK, Yiu KH, Siu CW, Ho HH. Heart Vessels. 2015 Jul;30(4):427-31.
  150. Net clinical benefit of warfarin therapy in elderly Chinese patients with atrial fibrillation. Siu CW, Tse HF. Circ Arrhythm Electrophysiol. 2014 Apr;7(2):300-6.
  151. Future of implantable devices for cardiac rhythm management. Lau CP, Siu CW, Tse HF. Circulation. 2014 Feb 18;129(7):811-22.
  152. Stroke patients with a past history of cancer are at increased risk of recurrent stroke and cardiovascular mortality. Lau KK, Wong YK, Teo KC, Chang RS, Hon SF, Chan KH, Cheung RT, Li LS, Tse HF, Ho SL, Siu CW. PLoS One. 2014 Feb 11;9(2):e88283.
  153. An upregulation in the expression of vanilloid transient potential channels 2 enhances hypotonicity-induced cytosolic Ca²⁺ rise in human induced pluripotent stem cell model of Hutchinson-Gillford Progeria. Lo CY, Tjong YW, Ho JC, Siu CW, Cheung SY, Tang NL, Yu S, Tse HF, Yao X. PLoS One. 2014 Jan 27;9(1):e87273.
  154. Long-term clinical outcomes of drug-eluting stents vs. bare-metal stents in Chinese geriatric patients. Chan PH, Liu SS, Tse HF, Chow WH, Jim MH, Ho HH, Siu CW. J Geriatr Cardiol. 2013 Dec;10(4):330-5.
  155. Modeling of Friedreich ataxia-related iron overloading cardiomyopathy using patient-specific-induced pluripotent stem cells. Lee YK, Ho PW, Schick R, Lau YM, Lai WH, Zhou T, Li Y, Ng KM, Ho SL, Esteban MA, Binah O, Tse HF, Siu CW. Pflugers Arch. 2014 Sep;466(9):1831-44.
  156. Visit-to-visit systolic blood pressure variability predicts all-cause and cardiovascular mortality after lacunar infarct. Lau KK, Wong YK, Chang RS, Teo KC, Hon SF, Chan KH, Wat KL, Cheung RT, Li LS, Siu CW, Ho SL, Tse HF. Eur J Neurol. 2014 Feb;21(2):319-25.
  157. Warfarin associated intracerebral hemorrhage in Hong Kong Chinese. Teo KC, Mahboobani NR, Lee R, Siu CW, Cheung RT, Ho SL, Lau KK, Chan KH. Neurol Res. 2014 Feb;36(2):143-9.
  158. Combined paclitaxel-eluting balloon and Genous cobalt-chromium alloy stent utilization in de novo coronary stenoses (PEGASUS). Jim MH, Fung RC, Yiu KH, Ng AK, Siu CW, Fan KY. J Interv Cardiol. 2013 Dec;26(6):556-60.
  159. Electrical stimulation promotes maturation of cardiomyocytes derived from human embryonic stem cells. Chan YC, Ting S, Lee YK, Ng KM, Zhang J, Chen Z, Siu CW, Oh SK, Tse HF. J Cardiovasc Transl Res. 2013 Dec;6(6):989-99.
  160. Prognostic value of preoperative right ventricular geometry and tricuspid valve tethering area in patients undergoing tricuspid annuloplasty. Yiu KH, Wong A, Pu L, Chiang MF, Sit KY, Chan D, Lee HY, Lam YM, Chen Y, Siu CW, Lau CP, Au WK, Tse HF. Circulation. 2014 Jan 7;129(1):87-92.
  161. Garlic intake is an independent predictor of endothelial function in patients with ischemic stroke. Lau KK, Chan YH, Wong YK, Teo KC, Yiu KH, Liu S, Li LS, Shu XO, Ho SL, Chan KH, Siu CW, Tse HF. J Nutr Health Aging. 2013 Jul;17(7):600-4.
  162. Human mesenchymal stem cells upregulate CD1dCD5(+) regulatory B cells in experimental autoimmune encephalomyelitis. Guo Y, Chan KH, Lai WH, Siu CW, Kwan SC, Tse HF, Wing-Lok Ho P, Wing-Man Ho J. Neuroimmunomodulation. 2013;20(5):294-303.
  163. Prevalence of and associations with reduced exercise capacity in peritoneal dialysis patients. Zuo ML, Yue WS, Yip T, Ng F, Lam KF, Yiu KH, Lui SL, Tse HF, Siu CW, Lo WK. Am J Kidney Dis. 2013 Nov;62(5):939-46.
  164. Association of subclinical myocardial injury with arterial stiffness in patients with type 2 diabetes mellitus. Yiu KH, Zhao CT, Chen Y, Siu CW, Chan YH, Lau KK, Liu S, Lau CP, Tse HF. Cardiovasc Diabetol. 2013 Jun 22;12:94.
  165. Predictive value of the HAS-BLED score for the risk of recurrent intracranial hemorrhage after first spontaneous intracranial hemorrhage. Chan KH, Ka-Kit Leung G, Lau KK, Liu S, Lui WM, Lau CP, Tse HF, Kan-Suen Pu J, Siu CW. World Neurosurg. 2014 Jul-Aug;82(1-2):e219-23.
  166. Relationship between parathyroid hormone and subclinical myocardial dysfunction in patients with severe psoriasis. Zhao CT, Yeung CK, Siu CW, Tam S, Chan J, Chen Y, Chan HH, Tse HF, Yiu KH. J Eur Acad Dermatol Venereol. 2014 Apr;28(4):461-8.
  167. Attenuation of hind-limb ischemia in mice with endothelial-like cells derived from different sources of human stem cells. Lai WH, Ho JC, Chan YC, Ng JH, Au KW, Wong LY, Siu CW, Tse HF. PLoS One. 2013;8(3):e57876.
  168. Pacing inducibility for atrial fibrillation: a test tested? Lau CP, Siu CW, Tse HF. J Cardiovasc Electrophysiol. 2013 Jun;24(6):624-5.
  169. Zotarolimus-eluting stent utilization in small-vessel coronary artery disease (ZEUS). Jim MH, Yiu KH, Fung RC, Ho HH, Ng AK, Siu CW, Chow WH. Heart Vessels. 2014 Jan;29(1):29-34.
  170. Chronotropic incompetence, echocardiographic abnormalities and exercise intolerance in renal transplant recipients. Ma MK, Zuo ML, Yap DY, Mok MM, Kwan LP, Chan GC, Siu DC, Chan TM. J Nephrol. 2014 Aug;27(4):451-6.
  171. Prolongation of PR interval is associated with endothelial dysfunction and activation of vascular repair in high-risk cardiovascular patients. Chan YH, Siu CW, Yiu KH, Yiu YF, Lau KK, Lam TH, Lau CP, Tse HF. J Interv Card Electrophysiol. 2013 Jun;37(1):55-61.
  172. The CHADS2 and CHA 2DS 2-VASc scores predict new occurrence of atrial fibrillation and ischemic stroke. Zuo ML, Liu S, Chan KH, Lau KK, Chong BH, Lam KF, Chan YH, Lau YF, Lip GY, Lau CP, Tse HF, Siu CW. J Interv Card Electrophysiol. 2013 Jun;37(1):47-54.
  173. Modeling of lamin A/C mutation premature cardiac aging using patient‐specific induced pluripotent stem cells. Siu CW, Lee YK, Ho JC, Lai WH, Chan YC, Ng KM, Wong LY, Au KW, Lau YM, Zhang J, Lay KW, Colman A, Tse HF. Aging (Albany NY). 2012 Nov;4(11):803-822.
  174. Ethnic differences in atrial fibrillation identified using implanted cardiac devices. Lau CP, Gbadebo TD, Connolly SJ, Van Gelder IC, Capucci A, Gold MR, Israel CW, Morillo CA, Siu CW, Abe H, Carlson M, Tse HF, Hohnloser SH, Healey JS; ASSERT investigators. J Cardiovasc Electrophysiol. 2013 Apr;24(4):381-7.
  175. Patient-specific induced-pluripotent stem cells-derived cardiomyocytes recapitulate the pathogenic phenotypes of dilated cardiomyopathy due to a novel DES mutation identified by whole exome sequencing. Tse HF, Ho JC, Choi SW, Lee YK, Butler AW, Ng KM, Siu CW, Simpson MA, Lai WH, Chan YC, Au KW, Zhang J, Lay KW, Esteban MA, Nicholls JM, Colman A, Sham PC. Hum Mol Genet. 2013 Apr 1;22(7):1395-403.
  176. Randomized controlled trial of vitamin D supplement on endothelial function in patients with type 2 diabetes. Yiu YF, Yiu KH, Siu CW, Chan YH, Li SW, Wong LY, Lee SW, Tam S, Wong EW, Lau CP, Cheung BM, Tse HF. Atherosclerosis. 2013 Mar;227(1):140-6.
  177. Angiographic and clinical outcomes of everolimus-eluting stent in the treatment of extra long stenoses (AEETES). Jim MH, Yiu KH, Ho HH, Chan WL, Ng AK, Siu CW, Chow WH. J Interv Cardiol. 2013 Feb;26(1):22-8.
  178. Myocardial dysfunction in patients with type 2 diabetes mellitus: role of endothelial progenitor cells and oxidative stress. Zhao CT, Wang M, Siu CW, Hou YL, Wang T, Tse HF, Yiu KH. Cardiovasc Diabetol. 2012 Dec 5;11:147.
  179. Atrial electrical and structural remodeling: implications for racial differences in atrial fibrillation. Lau CP, Tse HF, Siu CW, Gbadebo D. J Cardiovasc Electrophysiol. 2012 Nov;23 Suppl 1:S36-40.
  180. Frequent premature atrial complexes… truly a benign finding? Author reply. Siu CW. Europace. 2013 Feb;15(2):306-7.
  181. Prevalence and extent of subclinical atherosclerosis in patients with psoriasis. Yiu KH, Yeung CK, Zhao CT, Chan JC, Siu CW, Tam S, Wong CS, Yan GH, Yue WS, Khong PL, Chan HH, Tse HF. J Intern Med. 2013 Mar;273(3):273-82.
  182. Prognostic implications of surrogate markers of atherosclerosis in low to intermediate risk patients with type 2 diabetes. Lau KK, Wong YK, Chan YH, Yiu KH, Teo KC, Li LS, Ho SL, Chan KH, Siu CW, Tse HF. Cardiovasc Diabetol. 2012 Aug 18;11:101.
  183. Jeopardised Inferior Myocardium (JIM) score: an arithmetic electrocardiographic score to predict the infarct-related artery in inferior myocardial infarction. Jim MH, Tsui KL, Yiu KH, Cheung GS, Siu CW, Ho HH, Chow WH, Li SK. Ann Acad Med Singap. 2012 Jul;41(7):300-4.
  184. Sudden cardiac death after myocardial infarction in type 2 diabetic patients with no residual myocardial ischemia. Yeung CY, Lam KS, Li SW, Lam KF, Tse HF, Siu CW. Diabetes Care. 2012 Dec;35(12):2564-9.
  185. Association of lower habitual physical activity level with mitochondrial and endothelial dysfunction in patients with stable coronary artery disease. Luk TH, Dai YL, Siu CW, Yiu KH, Li SW, Fong B, Wong WK, Tam S, Tse HF. Circ J. 2012;76(11):2572-8.
  186. Prospective observational study of isoflavone and the risk of stroke recurrence: potential clinical implications beyond vascular function. Chan YH, Lau KK, Yiu KH, Siu CW, Chan HT, Li SW, Tam S, Lam TH, Lau CP, Tse HF. J Nutr Health Aging. 2012 Apr;16(4):383-8.
  187. Reversal of endothelial progenitor cell dysfunction in patients with type 2 diabetes using a conditioned medium of human embryonic stem cell-derived endothelial cells. Ho JC, Lai WH, Li MF, Au KW, Yip MC, Wong NL, Ng ES, Lam FF, Siu CW, Tse HF. Diabetes Metab Res Rev. 2012 Jul;28(5):462-73.
  188. Fatal lung toxic effects related to dronedarone use. Siu CW, Wong MP, Ho CM, Lam CL, Tse HF. Arch Intern Med. 2012 Mar 26;172(6):516-7.
  189. Long-term outcome and prognostic factors after spontaneous cerebellar hemorrhage. Pong V, Chan KH, Chong BH, Lui WM, Leung GK, Tse HF, Pu JK, Siu CW. Cerebellum. 2012 Dec;11(4):939-45.
  190. Myocardial ischemia due to congenital hypoplastic left coronary cusp in adult. Siu CW, Jim MH. Asian Cardiovasc Thorac Ann. 2012 Feb;20(1):91-2.
  191. Regulation of cell proliferation of human induced pluripotent stem cell-derived mesenchymal stem cells via ether-à-go-go 1 (hEAG1) potassium channel. Zhang J, Chan YC, Ho JC, Siu CW, Lian Q, Tse HF. Am J Physiol Cell Physiol. 2012 Jul 15;303(2):C115-25.
  192. Cardiac regeneration: messages from CADUCEUS. Siu CW, Tse HF. Lancet. 2012 Mar 10;379(9819):870-871.
  193. Lack of cardiac nerve sprouting after intramyocardial transplantation of bone marrow-derived stem cells in a swine model of chronic ischemic myocardium. Liu Y, Lai WH, Liao SY, Siu CW, Yang YZ, Tse HF. J Cardiovasc Transl Res. 2012 Jun;5(3):359-64.
  194. Subclinical left ventricular dysfunction revealed by circumferential 2D strain imaging in patients with coronary artery disease and fragmented QRS complex. Yan GH, Wang M, Yiu KH, Lau CP, Zhi G, Lee SW, Siu CW, Tse HF. Heart Rhythm. 2012 Jun;9(6):928-35.
  195. Left ventricular mechanical dyssynchrony impairs exercise capacity in patients with coronary artery disease with preserved left ventricular systolic function and a QRS duration ≤ 120 ms. Wang M, Yan GH, Yue WS, Siu CW, Yiu KH, Lee SW, Lau CP, Tse HF. Circ J. 2012;76(3):682-8.
  196. Adverse systemic arterial function in patients with selenium deficiency. Chan YH, Siu CW, Yiu KH, Chan HT, Li SW, Tam S, Cheung BM, Lau CP, Lam TH, Tse HF. J Nutr Health Aging. 2012 Jan;16(1):85-8.
  197. Use of aspirin in Chinese after recovery from primary intracranial haemorrhage. Chong BH, Chan KH, Pong V, Lau KK, Chan YH, Zuo ML, Lui WM, Leung GK, Lau CP, Tse HF, Pu JK, Siu CW. Thromb Haemost. 2012 Feb;107(2):241-7.
  198. Impact of glycemic control on circulating endothelial progenitor cells and arterial stiffness in patients with type 2 diabetes mellitus. Yue WS, Lau KK, Siu CW, Wang M, Yan GH, Yiu KH, Tse HF. Cardiovasc Diabetol. 2011 Dec 20;10:113.
  199. Frequent premature atrial complexes predict new occurrence of atrial fibrillation and adverse cardiovascular events. Chong BH, Pong V, Lam KF, Liu S, Zuo ML, Lau YF, Lau CP, Tse HF, Siu CW. Europace. 2012 Jul;14(7):942-7.
  200. Transient atrial fibrillation complicating acute myocardial infarction: a nuisance or a nemesis? Lam CC, Tse HF, Siu CW. Thromb Haemost. 2012 Jan;107(1):6-7.
  201. The CEPHEUS Pan-Asian survey: high low-density lipoprotein cholesterol goal attainment rate among hypercholesterolaemic patients undergoing lipid-lowering treatment in a Hong Kong regional centre. Chan RH, Chan PH, Chan KK, Lam SC, Hai JJ, Wong MK, Tam FC, Lam L, Chan CW, Lam YM, Siu DC, Tse HF, Lee SW. Hong Kong Med J. 2012 Oct;18(5):395-406.
  202. Pulmonary hypertension and isolated right heart failure complicating amiodarone induced hyperthyroidism. Wong SM, Tse HF, Siu CW. Heart Lung Circ. 2012 Mar;21(3):163-5.
  203. Thoracic spinal cord stimulation improves cardiac contractile function and myocardial oxygen consumption in a porcine model of ischemic heart failure. Liu Y, Yue WS, Liao SY, Zhang Y, Au KW, Shuto C, Hata C, Park E, Chen P, Siu CW, Tse HF. J Cardiovasc Electrophysiol. 2012 May;23(5):534-40.
  204. Hypertension and atrial fibrillation: epidemiology, pathophysiology and therapeutic implications. Lau YF, Yiu KH, Siu CW, Tse HF. J Hum Hypertens. 2012 Oct;26(10):563-9.
  205. Pacing to reduce refractory angina in patients with severe coronary artery disease: a crossover pilot trial. Stolen CM, Lam YM, Siu CW, Lau CP, Parker JA, Hauser TH, Tse HF. J Cardiovasc Transl Res. 2012 Feb;5(1):84-91.
  206. Cobalt chloride pretreatment promotes cardiac differentiation of human embryonic stem cells under atmospheric oxygen level. Ng KM, Chan YC, Lee YK, Lai WH, Au KW, Fung ML, Siu CW, Li RA, Tse HF. Cell Reprogram. 2011 Dec;13(6):527-37.
  207. Abnormal vascular function in PR-interval prolongation. Chan YH, Siu CW, Yiu KH, Li SW, Lau KK, Lam TH, Lau CP, Tse HF. Clin Cardiol. 2011 Oct;34(10):628-32.
  208. Thromboembolic risk of the hot- and cold-catheter ablation for atrial fibrillation. Siu CW, Tse HF. Heart Rhythm. 2012 Feb;9(2):197-8.
  209. Angiographic and long-term clinical outcome of the sleeve technique in treating in-stent restenotic bifurcation lesions: a preliminary experience. Jim MH, Ho HH, Yiu KH, Siu CW, Chow WH. Acute Card Care. 2011 Sep;13(3):159-63.
  210. Relationship between ventricular dyssynchrony and T-wave alternans in patients with coronary artery disease. Yan GH, Wang M, Yue WS, Yiu KH, Zhi G, Lau CP, Lee SW, Siu CW, Tse HF. Pacing Clin Electrophysiol. 2011 Nov;34(11):1503-10.
  211. Effect of exercise training on vascular endothelial function in patients with stable coronary artery disease: a randomized controlled trial. Luk TH, Dai YL, Siu CW, Yiu KH, Chan HT, Lee SW, Li SW, Fong B, Wong WK, Tam S, Lau CP, Tse HF. Eur J Prev Cardiol. 2012 Aug;19(4):830-9.
  212. Long-term oral nitrate therapy is associated with adverse outcome in diabetic patients following elective percutaneous coronary intervention. Yiu KH, Pong V, Siu CW, Lau CP, Tse HF. Cardiovasc Diabetol. 2011 Jun 13;10:52.
  213. Long-term clinical outcomes after intravascular brachytherapy for instent restenosis and de novo coronary artery lesions in percutaneous coronary intervention. Ho HH, Kwok OH, Jim MH, Siu CW, Pong V, Chow WH. Cardiovasc Revasc Med. 2011 May-Jun;12(3):152-157.
  214. Myocardial ischemia secondary to congenital hypoplastic left coronary cusp in adult. Siu CW, Jim MH. Acute Card Care. 2011 Sep;13(3):195.
  215. Calcium homeostasis in human induced pluripotent stem cell-derived cardiomyocytes. Lee YK, Ng KM, Lai WH, Chan YC, Lau YM, Lian Q, Tse HF, Siu CW. Stem Cell Rev Rep. 2011 Nov;7(4):976-86.
  216. Exogenous expression of human apoA-I enhances cardiac differentiation of pluripotent stem cells. Ng KM, Lee YK, Lai WH, Chan YC, Fung ML, Tse HF, Siu CW. PLoS One. 2011 May 11;6(5):e19787.
  217. Effect of herbal consumption on time in therapeutic range of warfarin therapy in patients with atrial fibrillation. Chan HT, So LT, Li SW, Siu CW, Lau CP, Tse HF. J Cardiovasc Pharmacol. 2011 Jul;58(1):87-90.
  218. Low molecular weight heparin versus unfractionated heparin for thromboprophylaxis in patients with acute atrial fibrillation: a randomized control trial. Siu CW, Jim MH, Lau CP, Tse HF. Acute Card Care. 2011 Sep;13(3):196-8.
  219. Effects of right low atrial septal vs. right atrial appendage pacing on atrial mechanical function and dyssynchrony in patients with sinus node dysfunction and paroxysmal atrial fibrillation. Wang M, Siu CW, Lee KL, Yue WS, Yan GH, Lee S, Lau CP, Tse HF. Europace. 2011 Sep;13(9):1268-74.
  220. Generation of induced pluripotent stem cell lines from 3 distinct laminopathies bearing heterogeneous mutations in lamin A/C. Ho JC, Zhou T, Lai WH, Huang Y, Chan YC, Li X, Wong NL, Li Y, Au KW, Guo D, Xu J, Siu CW, Pei D, Tse HF, Esteban MA. Aging (Albany NY). 2011 Apr;3(4):380-90.
  221. Hyperthyroidism-induced left ventricular diastolic dysfunction: implication in hyperthyroidism-related heart failure. Yue WS, Chong BH, Zhang XH, Liao SY, Jim MH, Kung AW, Tse HF, Siu CW. Clin Endocrinol (Oxf). 2011 May;74(5):636-43.
  222. Dietary intake of phytoestrogen is associated with increased circulating endothelial progenitor cells in patients with cardiovascular disease. Chan YH, Lam TH, Lau KK, Yiu KH, Siu CW, Li SW, Chan HT, Tam S, Lau CP, Tse HF. Eur J Cardiovasc Prev Rehabil. 2011 Jun;18(3):360-8.
  223. Type A aortic intramural hematoma: clinical features and outcomes in Chinese patients. Ho HH, Cheung CW, Jim MH, Miu KM, Siu CW, Lam YM, Chan HW, Lee WL, Tse HF. Clin Cardiol. 2011 Mar;34(3):E1-5.
  224. Reversal of mitochondrial dysfunction by coenzyme Q10 supplement improves endothelial function in patients with ischaemic left ventricular systolic dysfunction: a randomized controlled trial. Dai YL, Luk TH, Yiu KH, Wang M, Yip PM, Lee SW, Li SW, Tam S, Fong B, Lau CP, Siu CW, Tse HF. Atherosclerosis. 2011 Jun;216(2):395-401.
  225. Vitamin D deficiency is associated with depletion of circulating endothelial progenitor cells and endothelial dysfunction in patients with type 2 diabetes. Yiu YF, Chan YH, Yiu KH, Siu CW, Li SW, Wong LY, Lee SW, Tam S, Wong EW, Cheung BM, Tse HF. J Clin Endocrinol Metab. 2011 May;96(5):E830-5.
  226. Non-invasive screening of HLA-DPA1 and HLA-DPB1 alleles for persistent hepatitis B virus infection: susceptibility for vertical transmission and toward a personalized approach for vaccination and treatment. Lau KC, Lam CW, Law CY, Lai ST, Tsang TY, Siu CW, To WK, Leung KF, Mak CM, Poon WT, Chan PK, Chan YW. Clin Chim Acta. 2011 May 12;412(11-12):952-7.
  227. Left ventricular apical akinetic aneurysmatic area associated with permanent right ventricular apical pacing for advanced atrioventricular block: clinical characteristics and long-term outcome. Yiu KH, Siu CW, Zhang XH, Wang M, Lee KL, Lau CP, Tse HF. Europace. 2011 Apr;13(4):514-9.
  228. A shock in time saves ablation? Siu CW, Tse HF, Lau CP. Europace. 2011 Feb;13(2):155-6.
  229. Ouabain facilitates cardiac differentiation of mouse embryonic stem cells through ERK1/2 pathway. Lee YK, Ng KM, Lai WH, Man C, Lieu DK, Lau CP, Tse HF, Siu CW. Acta Pharmacol Sin. 2011 Jan;32(1):52-61.
  230. Preoperative cardiac risk assessment in geriatric patients with hip fractures: an orthopedic surgeons’ perspective. Siu CW, Sun NC, Lau TW, Yiu KH, Leung F, Tse HF. Osteoporos Int. 2010 Dec;21(Suppl 4):S587-91.
  231. Pre-operative pulmonary assessment for patients with hip fracture. Lo IL, Siu CW, Tse HF, Lau TW, Leung F, Wong M. Osteoporos Int. 2010 Dec;21(Suppl 4):S579-86.
  232. Peri-operative management of anti-platelet agents and anti-thrombotic agents in geriatric patients undergoing semi-urgent hip fracture surgery. Ho HH, Lau TW, Leung F, Tse HF, Siu CW. Osteoporos Int. 2010 Dec;21(Suppl 4):S573-7.
  233. Smoking is associated with depletion of circulating endothelial progenitor cells and elevated pulmonary artery systolic pressure in patients with coronary artery disease. Yue WS, Wang M, Yan GH, Yiu KH, Yin L, Lee SW, Siu CW, Tse HF. Am J Cardiol. 2010 Nov 1;106(9):1248-54.
  234. Prosthetic valve endocarditis in a multicenter registry of Chinese patients. Ho HH, Siu CW, Yiu KH, Tse HF, Chui WH, Chow WH. Asian Cardiovasc Thorac Ann. 2010 Oct;18(5):430-4.
  235. ROCK inhibition facilitates the generation of human-induced pluripotent stem cells in a defined, feeder-, and serum-free system. Lai WH, Ho JC, Lee YK, Ng KM, Au KW, Chan YC, Lau CP, Tse HF, Siu CW. Cell Reprogram. 2010 Dec;12(6):641-53.
  236. Proarrhythmic risk of embryonic stem cell-derived cardiomyocyte transplantation in infarcted myocardium. Liao SY, Liu Y, Siu CW, Zhang Y, Lai WH, Au KW, Lee YK, Chan YC, Yip PM, Wu EX, Wu Y, Lau CP, Li RA, Tse HF. Heart Rhythm. 2010 Dec;7(12):1852-9.
  237. Manual aspiration prior to stenting does not reduce the incidence of filter no reflow in saphenous vein graft lesions protected by FilterWire EX/EZ. Jim MH, Yiu KH, Ko RL, Ho HH, Siu CW, Chow WH. Acute Card Care. 2010 Sep;12(3):92-5.
  238. Elevated pulmonary artery systolic pressure in patients with coronary artery disease and left ventricular dyssynchrony. Yan GH, Wang M, Yue WS, Yiu KH, Siu CW, Lee SW, Lau CP, Tse HF. Eur J Heart Fail. 2010 Oct;12(10):1067-75.
  239. Pacing technology: advances in pacing threshold management. Lau CP, Siu CW. J Zhejiang Univ Sci B. 2010 Aug;11(8):634-8.
  240. Triiodothyronine promotes cardiac differentiation and maturation of embryonic stem cells via the classical genomic pathway. Lee YK, Ng KM, Chan YC, Lai WH, Au KW, Ho CY, Wong LY, Lau CP, Tse HF, Siu CW. Mol Endocrinol. 2010 Sep;24(9):1728-36.
  241. Attenuation of left ventricular adverse remodeling with epicardial patching after myocardial infarction. Liao SY, Siu CW, Liu Y, Zhang Y, Chan WS, Wu EX, Wu Y, Nicholls JM, Li RA, Benser ME, Rosenberg SP, Park E, Lau CP, Tse HF. J Card Fail. 2010 Jul;16(7):590-8.
  242. Safety and efficacy of oral anticoagulation therapy in Chinese patients with concomitant atrial fibrillation and hypertension. Ho LY, Siu CW, Yue WS, Lau CP, Lip GY, Tse HF. J Hum Hypertens. 2011 May;25(5):304-10.
  243. Long-term clinical outcomes of drug-eluting stents vs bare-metal stents in Chinese patients. Ho HH, Pong V, Siu CW, Jim MH, Miu R, Yiu KH, Ko R, Tse HF, Kwok OH, Chow WH. Clin Cardiol. 2010 Jun;33(6):E22-9.
  244. Virtual histology by intravascular ultrasound study on degenerative aortocoronary saphenous vein grafts. Jim MH, Hau WK, Ko RL, Siu CW, Ho HH, Yiu KH, Lau CP, Chow WH. Heart Vessels. 2010 May;25(3):175-81.
  245. Automaticity and conduction properties of bio-artificial pacemakers assessed in an in vitro monolayer model of neonatal rat ventricular myocytes. Chan YC, Tse HF, Siu CW, Wang K, Li RA. Europace. 2010 Aug;12(8):1178-87.
  246. Paclitaxel-eluting stents for chronically occluded saphenous vein grafts (EOS) study. Jim MH, Ho HH, Ko RL, Siu CW, Yiu KH, Lau CP, Chow WH. J Interv Cardiol. 2010 Feb;23(1):40-5.
  247. Mitochondrial dysfunction induced by statin contributes to endothelial dysfunction in patients with coronary artery disease. Dai YL, Luk TH, Siu CW, Yiu KH, Chan HT, Lee SW, Li SW, Tam S, Fong B, Lau CP, Tse HF. Cardiovasc Toxicol. 2010 Jun;10(2):130-8.
  248. Stem cells for myocardial repair. Siu CW, Liao SY, Liu Y, Lian Q, Tse HF. Thromb Haemost. 2010 Jul;104(1):6-12.
  249. Relationship between changes in heart rate recovery after cardiac rehabilitation on cardiovascular mortality in patients with myocardial infarction. Hai JJ, Siu CW, Ho HH, Li SW, Lee S, Tse HF. Heart Rhythm. 2010 Jul;7(7):929-36.
  250. Functional mesenchymal stem cells derived from human induced pluripotent stem cells attenuate limb ischemia in mice. Lian Q, Zhang Y, Zhang J, Zhang HK, Wu X, Zhang Y, Lam FF, Kang S, Xia JC, Lai WH, Au KW, Chow YY, Siu CW, Lee CN, Tse HF. Circulation. 2010 Mar 9;121(9):1113-23.
  251. Beta-blocker in post-myocardial infarct survivors with preserved left ventricular systolic function. Siu CW, Pong V, Jim MH, Yue WS, Ho HH, Li SW, Lau CP, Tse HF. Pacing Clin Electrophysiol. 2010 Jun 1;33(6):675-80.
  252. Exogenous expression of HIF-1 alpha promotes cardiac differentiation of embryonic stem cells. Ng KM, Lee YK, Chan YC, Lai WH, Fung ML, Li RA, Siu CW, Tse HF. J Mol Cell Cardiol. 2010 Jun;48(6):1129-37.
  253. Predicting recurrence of atrial fibrillation after electrical cardioversion: gauging atrial damage. Siu CW, Tse HF. Europace. 2010 Jun;12(6):764-5.
  254. Paclitaxel-Eluting Stents for Chronically Occluded Saphenous Vein Grafts (EOS) Study. Jim MH, Ho HH, Ko RL, Siu CW, Yiu KH, Lau CP, Chow WH. J Interv Cardiol. 2010 Jan 7.
  255. Contrast-enhanced computed tomography of adult scimitar syndrome (variant form). Siu CW, Cheung SC, Chan CW, Jim MH, Tse HF. Asian Cardiovasc Thorac Ann. 2009 Dec;17(6):662.
  256. Relationship of circulating endothelial progenitor cells to the recurrence of atrial fibrillation after successful conversion and maintenance of sinus rhythm. Siu CW, Watson T, Lai WH, Lee YK, Chan YH, Ng KM, Lau CP, Lip GY, Tse HF. Europace. 2010 Apr;12(4):517-21.
  257. Long term clinical outcomes after deployment of femoral vascular closure devices in coronary angiography and percutaneous coronary intervention. Lee SW, Ho HH, Kong SL, Lam YM, Siu CW, Miu KM, Lam L, Chan HW. Catheter Cardiovasc Interv. 2010 Feb 15;75(3):345-8.
  258. Virtual histology of aneurysmal lesion in aortocoronary saphenous vein graft. Jim MH, Yiu KH, Ko RL, Siu CW, Chow WH. Asian Cardiovasc Thorac Ann. 2009 Oct;17(5):539-40.
  259. Impact of right ventricular pacing sites on exercise capacity during ventricular rate regularization in patients with permanent atrial fibrillation. Tse HF, Siu CW, Lau CP. Pacing Clin Electrophysiol. 2009 Dec;32(12):1536-42.
  260. Are MADIT II criteria for implantable cardioverter defibrillator implantation appropriate for Chinese patients? Siu CW, Pong V, Ho HH, Liu S, Lau CP, Li SW, Tse HF. J Cardiovasc Electrophysiol. 2010 Mar;21(3):231-5.
  261. State-dependent accessibility of the P-S6 linker of pacemaker (HCN) channels supports a dynamic pore-to-gate coupling model. Siu CW, Azene EM, Au KW, Lau CP, Tse HF, Li RA. J Membr Biol. 2009 Jul;230(1):35-47.
  262. A rare case of severe aortic stenosis with preserved ejection fraction and normal transvalvular gradient. Ho HH, Siu CW, Lam YM, Lee HY, Tse HF. Int J Cardiol. 2011 Jun 16;149(3):e127-8.
  263. Interatrial mechanical dyssynchrony worsened atrial mechanical function in sinus node disease with or without paroxysmal atrial fibrillation. Wang M, Lau CP, Zhang XH, Siu CW, Lee KL, Yan GH, Yue WS, Tse HF. J Cardiovasc Electrophysiol. 2009 Nov;20(11):1237-43.
  264. Habitual physical activity is associated with endothelial function and endothelial progenitor cells in patients with stable coronary artery disease. Luk TH, Dai YL, Siu CW, Yiu KH, Chan HT, Fong DY, Lee SW, Li SW, Tam S, Lau CP, Tse HF. Eur J Cardiovasc Prev Rehabil. 2009 Aug;16(4):464-71.
  265. Long-term clinical and angiographic outcomes of the sleeve technique on non-left-main coronary bifurcation lesions. Jim MH, Ho HH, Ko RL, Siu CW, Yiu KH, Chow WH. EuroIntervention. 2009 May;5(1):104-8.
  266. Upgrading pacemaker patients with right ventricular apical pacing to right ventricular septal pacing improves left ventricular performance and functional capacity. Tse HF, Wong KK, Siu CW, Zhang XH, Ho WY, Lau CP. J Cardiovasc Electrophysiol. 2009 Aug;20(8):901-5.
  267. Intravenous diltiazem is superior to intravenous amiodarone or digoxin for achieving ventricular rate control in patients with acute uncomplicated atrial fibrillation. Siu CW, Lau CP, Lee WL, Lam KF, Tse HF. Crit Care Med. 2009 Jul;37(7):2174-9
  268. Focal pericarditis in a huge heart demonstrated by positron emission tomography/computed tomography. Yiu KH, Leung YL, Siu CW, Jim MH, Chow WH, Tse HF. Clin Nucl Med. 2009 Jun;34(6):362-4.
  269. Synergistic effects of inward rectifier (I) and pacemaker (I) currents on the induction of bioengineered cardiac automaticity. Chan YC, Siu CW, Lau YM, Lau CP, Li RA, Tse HF. J Cardiovasc Electrophysiol. 2009 Sep;20(9):1048-54.
  270. Impacts of ventricular rate regularization pacing at right ventricular apical vs. septal sites on left ventricular function and exercise capacity in patients with permanent atrial fibrillation. Tse HF, Wong KK, Siu CW, Tang MO, Tsang V, Ho WY, Lau CP. Europace. 2009 May;11(5):594-600.
  271. Facilitated maturation of Ca2+ handling properties of human embryonic stem cell-derived cardiomyocytes by calsequestrin expression. Liu J, Lieu DK, Siu CW, Fu JD, Tse HF, Li RA. Am J Physiol Cell Physiol. 2009 Jul;297(1):C152-9.
  272. A new ECG criterion to identify takotsubo cardiomyopathy from anterior myocardial infarction: role of inferior leads. Jim MH, Chan AO, Tsui PT, Lau ST, Siu CW, Chow WH, Lau CP. Heart Vessels. 2009 Mar;24(2):124-30.
  273. Absence of transverse tubules contributes to non-uniform Ca(2+) wavefronts in mouse and human embryonic stem cell-derived cardiomyocytes. Lieu DK, Liu J, Siu CW, McNerney GP, Tse HF, Abu-Khalil A, Huser T, Li RA. Stem Cells Dev. 2009 Dec;18(10):1493-500.
  274. Comparison of atrial fibrillation recurrence rates after successful electrical cardioversion in patients with hyperthyroidism-induced versus non-hyperthyroidism-induced persistent atrial fibrillation. Siu CW, Jim MH, Zhang X, Chan YH, Pong V, Kwok J, Kung AW, Lau CP, Tse HF. Am J Cardiol. 2009 Feb 15;103(4):540-3.
  275. Risk of ischemic stroke after new-onset atrial fibrillation in patients with hyperthyroidism. Siu CW, Pong V, Zhang X, Chan YH, Jim MH, Liu S, Yiu KH, Kung AW, Lau CP, Tse HF. Heart Rhythm. 2009 Feb;6(2):169-73.
  276. Determinants of lesion dimensions during transcatheter microwave ablation. Tse HF, Liao S, Siu CW, Yuan L, Nicholls J, Leung G, Ormsby T, Feld GK, Lau CP. Pacing Clin Electrophysiol. 2009 Feb;32(2):201-8.
  277. Cardiovascular flashlight. Multi-vessel coronary artery spasm. Ho HH, Siu CW, Lee WL. Eur Heart J. 2009 May;30(10):1212.
  278. Angiographic and clinical implications of combined ST-segment elevation in anterior and inferior leads in acute myocardial infarction. Jim MH, Chan AO, Tang MO, Siu CW, Lee SW, Lau CP. Clin Cardiol. 2009 Jan;32(1):21-7.
  279. Effects of iron oxide nanoparticles on cardiac differentiation of embryonic stem cells. Au KW, Liao SY, Lee YK, Lai WH, Ng KM, Chan YC, Yip MC, Ho CY, Wu EX, Li RA, Siu CW, Tse HF. Biochem Biophys Res Commun. 2009 Feb 20;379(4):898-903.
  280. Paclitaxel-eluting stent long-term outcomes in percutaneous saphenous vein graft interventions (PELOPS) study. Jim MH, Ho HH, Ko RL, Yiu KH, Siu CW, Lau CP, Chow WH. Am J Cardiol. 2009 Jan 15;103(2):199-202.
  281. Alleviation of pulmonary hypertension by cardiac resynchronization therapy is associated with improvement in central sleep apnea. Yiu KH, Lee KL, Lau CP, Siu CW, Miu KM, Lam B, Lam J, Ip MS, Tse HF. Pacing Clin Electrophysiol. 2008 Dec;31(12):1522-7.
  282. Scimitar syndrome on chest x ray. Siu CW, Cheung SC, Chan CW, Lam YM, Tse HF, Jim MH. Postgrad Med J. 2008 Oct;84(996):558.
  283. Amiodarone-induced thyrotoxicosis is a predictor of adverse cardiovascular outcome. Yiu KH, Jim MH, Siu CW, Lee CH, Yuen M, Mok M, Shea YF, Fan K, Tse HF, Chow WH. J Clin Endocrinol Metab. 2009 Jan;94(1):109-14.
  284. Traumatic ventricular septal defect. Jim MH, Lam YM, Siu CW, Chan RH. Asian Cardiovasc Thorac Ann. 2008 Oct;16(5):436.
  285. Analysis of ventricular performance as a function of pacing site and mode. Siu CW, Wang M, Zhang XH, Lau CP, Tse HF. Prog Cardiovasc Dis. 2008 Sep-Oct;51(2):171-82.
  286. Overexpression of HCN-encoded pacemaker current silences bioartificial pacemakers. Lieu DK, Chan YC, Lau CP, Tse HF, Siu CW, Li RA. Heart Rhythm. 2008 Sep;5(9):1310-7.
  287. Pericarditis induced by active-fixation lead shown by positron emission tomography/computed tomography. Yiu KH, Siu CW, Lau CP, Tse HF. Heart Rhythm. 2008 Oct;5(10):1493-4.
  288. New-onset heart failure after permanent right ventricular apical pacing in patients with acquired high-grade atrioventricular block and normal left ventricular function. Zhang XH, Chen H, Siu CW, Yiu KH, Chan WS, Lee KL, Chan HW, Lee SW, Fu GS, Lau CP, Tse HF. J Cardiovasc Electrophysiol. 2008 Feb;19(2):136-41.
  289. Structural and functional determinants in the S5-P region of HCN-encoded pacemaker channels revealed by cysteine-scanning substitutions. Au KW, Siu CW, Lau CP, Tse HF, Li RA. Am J Physiol Cell Physiol. 2008 Jan;294(1):C136-44.
  290. Genomic changes in regenerated porcine coronary arterial endothelial cells. Lee MY, Tse HF, Siu CW, Zhu SG, Man RY, Vanhoutte PM. Arterioscler Thromb Vasc Biol. 2007 Nov;27(11):2443-9.
  291. Use of the Interact Short Form as a tool to evaluate emotion of people with profound intellectual disabilities. Liu KP, Lee T, Yan A, Siu CW, Choy FW, Leung KL, Siu TY, Kwan AC. J Intellect Disabil Res. 2007 Nov;51(Pt 11):884-91.
  292. Functional sarcoplasmic reticulum for calcium handling of human embryonic stem cell-derived cardiomyocytes: insights for driven maturation. Liu J, Fu JD, Siu CW, Li RA. Stem Cells. 2007 Dec;25(12):3038-44.
  293. Human embryonic stem cell-derived cardiomyocytes for heart therapies. Siu CW, Moore JC, Li RA. Cardiovasc Hematol Disord Drug Targets. 2007 Jun;7(2):145-52.
  294. HCN-encoded pacemaker channels: from physiology and biophysics to bioengineering. Siu CW, Lieu DK, Li RA. J Membr Biol. 2006;214(3):115-22.
  295. Paracrine effects of direct intramyocardial implantation of bone marrow derived cells to enhance neovascularization in chronic ischaemic myocardium. Tse HF, Siu CW, Zhu SG, Songyan L, Zhang QY, Lai WH, Kwong YL, Nicholls J, Lau CP. Eur J Heart Fail. 2007 Aug;9(8):747-53.
  296. Transient atrial fibrillation complicating acute inferior myocardial infarction: implications for future risk of ischemic stroke. Siu CW, Jim MH, Ho HH, Miu R, Lee SW, Lau CP, Tse HF. Chest. 2007 Jul;132(1):44-9.
  297. Mechanistic role of I(f) revealed by induction of ventricular automaticity by somatic gene transfer of gating-engineered pacemaker (HCN) channels. Xue T, Siu CW, Lieu DK, Lau CP, Tse HF, Li RA. Circulation. 2007 Apr 10;115(14):1839-50.
  298. Hemodynamic changes in hyperthyroidism-related pulmonary hypertension: a prospective echocardiographic study. Siu CW, Zhang XH, Yung C, Kung AW, Lau CP, Tse HF. J Clin Endocrinol Metab. 2007 May;92(5):1736-42.
  299. Transvenous catheter-based microwave ablation for atrial flutter. Yiu KH, Siu CW, Lau CP, Lee KL, Tse HF. Heart Rhythm. 2007 Feb;4(2):221-3.
  300. Value of ST-segment depression in lead V4R in predicting proximal against distal left circumflex artery occlusion in acute inferoposterior myocardial infarction. Jim MH, Ho HH, Siu CW, Miu R, Chan CW, Lee SW, Lau CP. Clin Cardiol. 2007 Jan;30(1):36-41.
  301. Cardiac resynchronization therapy optimization by ultrasonic cardiac output monitoring (USCOM) device. Siu CW, Tse HF, Lee K, Chan HW, Chen WH, Yung C, Lee S, Lau CP. Pacing Clin Electrophysiol. 2007 Jan;30(1):50-5.
  302. Impaired nitrate-mediated dilatation could reflect nitrate tolerance in patients with coronary artery disease. Hu R, Siu CW, Lau EO, Wang WQ, Lau CP, Tse HF. Int J Cardiol. 2007 Sep 3;120(3):351-6.
  303. Emerging trends of community acquired infective endocarditis. Yiu KH, Siu CW, Lee KL, Fong YT, Chan HW, Lee SW, Lau CP, Tse HF. Int J Cardiol. 2007 Sep 14;121(1):119-22.
  304. A patient with relapsing pacemaker infection due to “Gram-positive bacilli”. Siu CW, Cheng LC, Woo PC, Lau CP, Tse HF. Int J Cardiol. 2007 Jan 8;114(2):E40-1.
  305. Leukocytosis and clinical outcomes in acute inferior myocardial infarction. Ho HH, Jim MH, Siu CW, Miu KM, Chan HW, Lee WL, Lau CP, Tse HF. Int J Cardiol. 2007 May 31;118(2):278-9.
  306. Incidence, clinical characteristics and outcome of congestive heart failure as the initial presentation in patients with primary hyperthyroidism. Siu CW, Yeung CY, Lau CP, Kung AW, Tse HF. Heart. 2007 Apr;93(4):483-7.
  307. Prognostic implications of PR-segment depression in inferior leads in acute inferior myocardial infarction. Jim MH, Siu CW, Chan AO, Chan RH, Lee SW, Lau CP. Clin Cardiol. 2006 Aug;29(8):363-8.
  308. Bioartificial sinus node constructed via in vivo gene transfer of an engineered pacemaker HCN Channel reduces the dependence on electronic pacemaker in a sick-sinus syndrome model. Tse HF, Xue T, Lau CP, Siu CW, Wang K, Zhang QY, Tomaselli GF, Akar FG, Li RA. Circulation. 2006 Sep 5;114(10):1000-11.
  309. Avoidance of electromagnetic interference to implantable cardiovertor-defibrillator during atrioventricular node ablation for atrial fibrillation using transvenous cryoablation. Siu CW, Tse HF, Lau CP. Pacing Clin Electrophysiol. 2006 Aug;29(8):914-6.
  310. Endocardial visualization of esophageal-left atrial anatomic relationship by three-dimensional multidetector computed tomography “navigator imaging”. Wang SL, Ooi CG, Siu CW, Yiu MW, Pang C, Lau CP, Tse HF. Pacing Clin Electrophysiol. 2006 May;29(5):502-8.
  311. A rare cause of infective endocarditis; Lactococcus garvieae. Yiu KH, Siu CW, To KK, Jim MH, Lee KL, Lau CP, Tse HF. Int J Cardiol. 2007 Jan 8;114(2):286-7.
  312. Prevalence of colorectal neoplasm among patients with newly diagnosed coronary artery disease. Chan AO, Jim MH, Lam KF, Morris JS, Siu DC, Tong T, Ng FH, Wong SY, Hui WM, Chan CK, Lai KC, Cheung TK, Chan P, Wong G, Yuen MF, Lau YK, Lee S, Szeto ML, Wong BC, Lam SK. JAMA. 2007 Sep 26;298(12):1412-9. doi: 10.1001/jama.298.12.1412.
  313. Coexistence between colorectal cancer/adenoma and coronary artery disease: results from 1382 patients. Chan AO, Lam KF, Tong T, Siu DC, Jim MH, Hui WM, Lai KC, Yuen MF, Lam SK, Wong BC. Aliment Pharmacol Ther. 2006 Aug 1;24(3):535-9.
  314. Effects of oral arsenic trioxide therapy on QT intervals in patients with acute promyelocytic leukemia: implications for long-term cardiac safety. Siu CW, Au WY, Yung C, Kumana CR, Lau CP, Kwong YL, Tse HF. Blood. 2006 Jul 1;108(1):103-6.
  315. Comparison of the efficacy and safety profiles of intravenous vitamin K and fresh frozen plasma as treatment of warfarin-related over-anticoagulation in patients with mechanical heart valves. Yiu KH, Siu CW, Jim MH, Tse HF, Fan K, Chau MC, Chow WH. Am J Cardiol. 2006 Feb 1;97(3):409-11.
  316. The incremental benefit of rate-adaptive pacing on exercise performance during cardiac resynchronization therapy. Tse HF, Siu CW, Lee KL, Fan K, Chan HW, Tang MO, Tsang V, Lee SW, Lau CP. J Am Coll Cardiol. 2005 Dec 20;46(12):2292-7.
  317. Inappropriate implantable cardioverter defibrillator shock from a transcutaneous muscle stimulation device therapy. Siu CW, Tse HF, Lau CP. J Interv Card Electrophysiol. 2005 Jun;13(1):73-5. doi: 10.1007/s10840-005-0357-3.
  318. Anomalous origin of right coronary artery from the left coronary sinus: incidence, characteristics, and a systematic approach for rapid diagnosis. Jim MH, Siu CW, Ho HH, Miu R, Lam YM, Lam L, Chan RH, Lee SW. J Interv Cardiol. 2005 Apr;18(2):101-6.
  319. Successful pulmonary vein isolation using transvenous catheter cryoablation improves quality-of-life in patients with atrial fibrillation. Tse HF, Sin PY, Siu CW, Tsang V, Lam CL, Lau CP. Pacing Clin Electrophysiol. 2005 May;28(5):421-4.
  320. Recurrent acute heart failure caused by sliding hiatus hernia. Siu CW, Jim MH, Ho HH, Chu F, Chan HW, Lau CP, Tse HF. Postgrad Med J. 2005 Apr;81(954):268-9.
  321. Effects of temporal application parameters on lesion dimensions during transvenous catheter cryoablation. Tse HF, Ripley KL, Lee KL, Siu CW, Van Vleet JF, Pelkey WL, Lau CP. J Cardiovasc Electrophysiol. 2005 Feb;16(2):201-4.
  322. Blood pressure response to transition from supine to standing posture using an orthostatic response algorithm. Tse HF, Siu CW, Tsang V, Yu C, Park E, Bornzin GA, Benser ME, Lau CP. Pacing Clin Electrophysiol. 2005 Jan;28 Suppl 1:S242-5.
  323. Prevalence and predictors of new-onset atrial fibrillation after elective surgery for colorectal cancer. Siu CW, Tung HM, Chu KW, Jim MH, Lau CP, Tse HF. Pacing Clin Electrophysiol. 2005 Jan;28 Suppl 1:S120-3.
  324. Pulmonary artery obstruction mimicking the clinical features of acute pulmonary embolism. Siu CW, Jim MH, Tse HF. Heart. 2005 Feb;91(2):212.
  325. Effect of a cardiac rehabilitation program on left ventricular diastolic function and its relationship to exercise capacity in patients with coronary heart disease: experience from a randomized, controlled study. Yu CM, Li LS, Lam MF, Siu DC, Miu RK, Lau CP. Am Heart J. 2004 May;147(5):e24.
  326. Anomalous origin of the right coronary artery from the left coronary sinus is associated with early development of coronary artery disease. Jim MH, Siu CW, Ho HH, Miu R, Lee SW. J Invasive Cardiol. 2004 Sep;16(9):466-8.
  327. HBsAg seroclearance in chronic hepatitis B in the Chinese: virological, histological, and clinical aspects. Yuen MF, Wong DK, Sablon E, Tse E, Ng IO, Yuan HJ, Siu CW, Sander TJ, Bourne EJ, Hall JG, Condreay LD, Lai CL. Hepatology. 2004 Jun;39(6):1694-701.
  328. PR-segment elevation in inferior leads: an atypical electrocardiographic sign of atrial infarction. Jim MH, Miu R, Siu CW. J Invasive Cardiol. 2004 Apr;16(4):219-21.
  329. Transient giant R-wave, right axis deviation, and intraventricular conduction delay during exercise treadmill testing: a case report. Jim MH, Siu CW, Lee SW, Lam L, Chan RH. J Electrocardiol. 2004 Jan;37(1):61-6.
  330. Prevention of atrial fibrillation recurrence by statin therapy in patients with lone atrial fibrillation after successful cardioversion. Siu CW, Lau CP, Tse HF. Am J Cardiol. 2003 Dec 1;92(11):1343-5.
  331. Recombinant interferon alfa 2b therapy in a patient with metastatic hepatocellular carcinoma. Yuen MF, Hon C, Hui CK, Siu CW, Lai CL. J Clin Gastroenterol. 2002 Sep;35(3):272-5.
  332. Association between anti-thymocyte globulin administration and cytomegalic virus infection and/or CMV disease in cadaveric renal allograft recipients. Siu CW, Chan TM, Li FK, Choy BY, Lui SL, Lo CY, Tang S, Lo WK, Lai KN. Transplant Proc. 2000 Nov;32(7):1932-4.
  333. Carcinoma of the colon with synchronous hepatic metastasis in a cirrhotic liver harboring a hepatocellular carcinoma. Siu DC, Lam CM, Yuen ST, Fan ST. Hepatogastroenterology. 1999 Jul-Aug;46(28):2355-7.